» Publications

SCI-SSCI or SCI Expanded Articles

Ümit EG, Demir AM, Ar MC, Ayer M, Aylı M, Karakuş V, Kaya E, Özkalemkaş F, Sayınalp N, Sönmez M, Şahin F, Toprak SK, Toptaş T, Yavaşoğlu İ, Çalış Ü. Management of Primary Immune Thrombocytopenia: Turkish Modified Delphi-Based Consensus Statement for Special Considerations. Turk J Haematol. 2024 Aug 28;41(3):141-145. doi: 10.4274/tjh.galenos.2024.2024.0101. (September 2024)

Ümit E, Baysal M, Kırkızlar HO, Demir AM. Myeloproliferative Neoplasm Symptom Assessment Total Symptom Score (MPN-SAF TSS) in Chronic Myeloproliferative Neoplasms, Related with Genetic Burden, and Thrombosis. Turk J Haematol. 2024 May 27. doi: 10.4274/tjh.galenos.2024.2024.0011. (June 2024)

Demir AM, Ümit EG, Ar MC, Ayer M, Aylı M, Karakuş V, Kaya E, Özkalemkaş F, Sayınalp N, Sönmez M, Şahin F, Toprak SK, Toptaş T, Yavaşoğlu İ, Çalış Ü.Management of Adult Primary Immune Thrombocytopenia: Delphi-Based Consensus Recommendations. Turk J Haematol. 2024 May 30;41(2):97-104. doi: 10.4274/tjh.galenos.2024.2024.0055. (June 2024)

Sarcopenia in patients with multiple myeloma and autologous hematopoietic stem cell transplantation. Demirci U, Korkmaz U, Umit EG, Demir AM. North Clin Istanb. DOI: 10.14744/nci.2024.00878 (April 2024)

Akkus E, Tuncalı T, Akın HY, Aydın Y, Beşışık SK, Gürkan E, Ratip S, Salihoğlu A, Sargın D, Ünal A, Turcan A, Sevindik ÖG, Demir M, Beksac M. Germline genetic variants in Turkish familial multiple myeloma/monoclonal gammopathy of undetermined significance cases. Br J Haematol. 2023 Dec 20. doi: 10.1111/bjh.19271. (December 2023)

Baysal M, Hindilerden F, Ümit EG, Demir AM, Keklik Karadağ F, Saydam G, Akpınar S, Turgut B, Özkocaman V, Özkalemkaş F, Çiftçiler R, Özlü C, Demircioğlu S, İpek Y, Diz Küçükkaya R. Immune Thrombotic Thrombocytopenic Purpura in Elderly Patients: The Roles of PLASMIC and French Scores. Turk J Haematol. 2023 Dec 5;40(4):251-257. doi: 10.4274/tjh.galenos.2023.2023.0295. Epub 2023 Oct 4.PMID: 37791641 (December 2023)

Catherine M Broome, Vickie McDonald, Yoshitaka Miyakawa, Monica Carpenedo, David J Kuter, Hanny Al-Samkari, James B Bussel, Marie Godar, Jaume Ayguasanosa, Kristof De Beuf, Francesco Rodeghiero, Marc Michel, Adrian Newland, Michael Fillitz, Paul Knoebl, Stef Meers, Ismail Mohamad Amine, Jaromir Gumulec, Antonin Hlusi, Jiri Mayer, Philippe Quittet, Jean-Francois Viallard, Magdana Betaneli, Irine Datikashvili-David, Genadi Iosava, Levan Makhaldiani, Laszlo Rejto, Nino Sharashenidze, Stefanie Groepper, Alexander Röth, Aryan Hamed, Arpad Illes, Andrea Artoni, Monica Bocchia, Barbara Gamberi, Alessandra Borchiellini, Esther Natalie Oliva, Andrea Patriarca, Simona Tomassetti, Kiyoshi Ando, Hiroshi Handa, Shinya Katsutani, Kaichi Nishiwaki, Shoko Ito, Tomoki Ito, Fransien de Boer, AJ Gerard Jansen, Hanna Ciepluch, Szymon Fornagiel, Sebastian Grosicki, Maria Soroka-Wojtaszko, Jacek Trelinski, Bulat Bakirov, Elena Borisenkova, Elena Volodicheva, Yuri Shatokhin, Andrey Proydakov, Maria Aranzazu Alonso, María Eva Mingot-Castellano, Blanca Sanchez-Gonzalez, David Valcarcel Ferreiras, Meltem Ayli, Tuba Hacibekiroglu, Ahmet Muzaffer Demir, Meliha Nalçaci, Mehmet Sonmez, Anil Tombak, Selami Kocak Toprak, Burhan Turgut, Filiz Vural, Munci Yagci, Fevzi Altuntas, Mehmet Turgut, Emin Kaya, Nataliya Romanyuk, Syed Rashid Saeed Kazmi, Catherine Broome, Spero Cataland, Ketan Doshi, Steven R Lentz, Michael Boxer, Richard Rosenberg. Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial. The Lancet 2023; 402(10413):1648-1659 (November 2023)

2
ATIF

Demirci U, Erbilen EA, Ümit EG, İnan C, Sayın NC, Demir AM. Successful pregnancy and delivery management in a patient with Bernard Soulier Syndrome. Obstet Med. 2023 Sep;16(3):203-205. doi: 10.1177/1753495X211067119. Epub 2022 Jan 13. PMID: 37719997 (September 2023)

1
ATIF

Demirci U, Umit EG, Baysal M, Demir AM. Morphologic evaluation of megakaryocytes in immune thrombocytopenia patients older than 80 years. North Clin Istanb. 2023 Aug 9;10(4):477-783. doi: 10.14744/nci.2022.57124. eCollection 2023.PMID: 37719257 (August 2023)

1
ATIF

Demir AM, Ar MC, Şahin F, Altunbaş M.Level of Awareness of Acquired Hemophilia A Among Physicians in Türkiye: A Survey Study. Turk J Haematol. 2023 Aug 31;40(3):197-201. doi: 10.4274/tjh.galenos.2023.2023.0236. PMID: 37649419 (August 2023)

Demirci U, Yüksel MK, Kırkızlar HO, Ateşoğlu EB, Mehtap Ö, Salim O, Demir AM, Akay OM. A survey evaluating hematology physicians’ perspectives on central nervous system prophylaxis. Blood Res. 2023 Jun 30;58(2):99-104. doi: 10.5045/br.2023.2023066. Epub 2023 Jun 8.PMID: 37292008 (June 2023)

Kirkizlar TA, Kirkizlar O, Demirci U, Umut A, Iflazoglu H, Umit EG, Demir AM. Incidence and predisposing factors of infection in patients treated with hypomethylating agents. Leuk Res. 2023 Apr;127:107043. doi: 10.1016/j.leukres.2023.107043. Epub 2023 Feb 15. PMID: 36801588 (February 2023)

2
ATIF

Ufuk Demirci, Hakkı Onur Kırkızlar, Elif G Ümit, Vildan Gürsoy, İbrahim Ethem Pınar, Fahir Özkalemkaş, Zeynep Tuğba Güven, Leylagül Kaynar, Fatma Keklik Karadağ, Güray Saydam, Ömer Ekinci, Mustafa Merter, Merih Reis Aras, Murat Albayrak, Sedanur Karaman Gülsaran, Volkan Baş, Berrin Balık Aydın, Hüseyin Saffet Beköz, Ferda Can, İmdat Dilek, Özgür Mehtap, Erman Öztürk, Bengü Çöbanoğlu Şimşek, Murat Yıldırım, Meltem Aylı, Ünal Ataş, Ozan Salim, Mesut Ayer, Elif Birtaş Ateşoğlu, Olga Meltem Akay, Meltem Kurt Yüksel, Semra Paydaş, Selçuk Korkmaz, Fulya Öz Puyan, Ahmet Muzaffer Demir. CD5 as a prognostic marker in patients with diffuse large B-cell lymphoma: a multicenter study Journal of Hematopathology 2022;15(4):203-213 (December 2022)

Dominique Farge, Corinne Frere, Jean M Connors, Alok A Khorana, Ajay Kakkar, Cihan Ay, Andres Muñoz, Benjamin Brenner, Pedro H Prata, Dialina Brilhante, Darko Antic, Patricia Casais, María Cecilia Guillermo Esposito, Takayuki Ikezoe, Syed A Abutalib, Luis A Meillon-García, Henri Bounameaux, Ingrid Pabinger, James Douketis, Walter Ageno, Fernando Ajauro, Thierry Alcindor, Pantep Angchaisuksiri, Juan I Arcelus, Raquel Barba, Ali Bazarbachii, Audrey Bellesoeur, Okba Bensaoula, Ilham Benzidia, Darius Bita, Viktoria Bitsadze, Dorit Blickstein, Mark Blostein, Isabel Bogalho, Antonio Brandao, Rodrigo Calado, Antoine Carpentier, Jose Manuel Ceresetto, Rufaro Chitsike, Jérôme Connault, Catarina Jacinto Correia, Benjamin Crichi, Erich V De Paula, Ahmet M Demir, Laure Deville, Ludovic Doucet, Vera Dounaevskaia, Cécile Durant, Martin Ellis, Joseph Emmerich, Anna Falanga, Carme Font, Enrique Gallardo, Thomas Gary, Filipe Gonçalves, Jean-Christophe Gris, Hiromi Hayashi, Adrian Hij, Luis Jara-Palomares, David Jiménez, Jamilya Khizroeva, Michel N'Guessan, Florian Langer, Claire Le Hello, Christine Le Maignan, Ramón Lecumberri, Lai Heng Lee, Zachary Liederman, Luisa Lopes dos Santos, Duarte Henrique Machado, Alexander Makatsariya, Alberto Maneyro, Zora Marjanovic, Serban Milhaileanu, Manuel Monreal, Sara Morais, Antonio Moreira, Mikio Mukai, Arlette Ndour, Luciana Correa Oliveira, Remedios Otero-Candelara, Maria Carolina Tostes Pintao, Florian Posch, Pascal Prilollet, Hanadi Rafii, Daniel Dias Ribeiro, Hanno Riess, Marc Righini, Helia Robert-Ebadi, Cynthia Rothschild, Andre Roussin, José Antonio Rueda Camino, Pedro Ruiz-Artacho, Gleb Saharov, Joana Santos, Maxime Sebuhyan, Ali Shamseddine, Galia Spectre Spectre, Ali Taher, Javier Trujillo-Santos, Inna Tzoran, Stéphane Villiers, Raymond Wong, Yugo Yamashita, Alexandra Yannoutsos, Chikao Yasuda. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19. The Lancet Oncology 23 (7), e334-e347 (July 2022)

2
ATIF

Baysal M, Gürsoy V, Hunutlu FC, Erkan B, Demirci U, Bas V, Gulsaran SK, Pinar IE, Ersal T, Kirkizlar TA, Atli EI, Kirkizlar HO, Ümit EG, Gürkan H, Ozkocaman V, Ozkalemkas F, Demir AM, Ali R. The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study. Ann Hematol. 2022 May;101(5):1049-1057. doi: 10.1007/s00277-022-04798-8. Epub 2022 Feb 21.PMID: 35190843 (May 2022)

Saydam G, Ali R, Demir AM, Eskazan AE, Guvenc B, Haznedaroglu IC, Ozcan MA, Salim O, Sonmez M, Tuglular AT, Turgut M, Unal A, Aver B, Bozkurt S, Ozdengulsun B, Ilhan O. The effect of comorbidities on the choice of tyrosine kinase inhibitors in patients with chronic myeloid leukemia. Int J Hematol Oncol. 2022 May 24;11(1):IJH38. doi: 10.2217/ijh-2021-0010. eCollection 2022 Mar.PMID: 35664044 (May 2022)

3
ATIF

Demirci, U, Gulsaran, SK, Bas, V, Umit, EG, Kirkizlar, HO, Demir, AM. Management of Patients with Factor VII Deficiency in Surgery: A Single-center Experience Erciyes Medical Journal.2022; 44(2): 222-228 (March 2022)

Improving Care of Older Patients with Hemophilia During COVID-19 Pandemic, Reducing the Risk of Venous Thrombosis with Home Exercises. Demirci U, Umit EG, Ozdemir H, Demirbag Kabayel D, Demir AM. Clin App Thromb Hemost March 18, 2022 https://doi.org/10.1177/10760296221087223 (March 2022)

Baysal M, Baş V, Ümit E, Kırkızlar HO, Demir AM. Could Antinuclear Antibody Positivity Be a Factor Affecting Treatment Response in Immune Thrombocytopenia Patients on Eltrombopag? Turk J Haematol. 2022 Feb 23;39(1):38-42. doi: 10.4274/tjh.galenos.2021.2021.0183. Epub 2021 Jun 24.PMID: 34162172 (February 2022)

.AKDENIZ AYDAN, ÜNÜVAR AYSEGÜL, AR MUHLIS CEM, PEKPAK SAHINOGLU ESRA, MEHTAP ÖZGÜR, AKYAY ARZU, KEKLIK KARADAG FATMA, ACIPAYAM CAN, DOGAN ALI, Ekinci Ömer, Aydin Köker Sultan, Albayrak Canan, DEMIRCI UFUK, GÜNEY TEKIN, Kurt Meltem, KARAMAN SERAP, SAHIN KIMYON ÖZGE, ALBAYRAK SINAN, ÖNCÜL YURDAY, ÜNAL SERKAN, SAHIN FAHRI, TUNA DEVECI RUMEYSA, ZÜLFIKAR OSMAN BÜLENT, BELEN APAK FATMA BURCU, ÜMIT ELIF GÜLSÜM, DEMIR AHMET MUZAFFER, Results of multicenter registry for patients with inherited factor VII deficiency in Turkey., Scand J Clin Lab Invest. 2022 Feb;82(1):28-36. doi: 10.1080/00365513.2021.2013524. (February 2022)

.CIVRIZ BOZDAG SINEM, CENGIZ SEVAL GÜLDANE, YÖNAL HINDILERDEN IPEK, HINDILERDEN FEHMI, ANDIÇ NESLIHAN, BAYDAR MUSTAFA, AYDIN KAYNAR LALE, TOPRAK SELAMI KOÇAK, GÖKSOY HASAN SAMI, BALIK AYDIN BERRIN, DEMIRCI UFUK, CAN FERDA, ÖZKOCAMAN VILDAN, GÜNDÜZ EREN, GÜVEN ZEYNEP TUGBA, ÖZKURT ZÜBEYDE NUR, DEMIRCIOGLU SINAN, BEKSAÇ MERAL, INCE IDRIS, YILMAZ UMUT, EROGLU KÜÇÜKDILLER HILAL, ABISHOV ELGÜN, YAVUZ BORAN, ATAS ÜNAL, MUTLU YASA GÜL, BAS VOLKAN, ÖZKALEMTAS FAHIR, ÜSKÜDAR TEKE HAVA, GÜRSOY VILDAN, ÇELIK SERHAT, ÇIFÇILER RAFIYE, YAGCI ABDULLAH MÜNCI, TOPÇUOGLU PERVIN, ÇENELI ÖZCAN, ABBASOV HAMZA, SELIM CEM, AR MUHLIS CEM, YÜCEL ORHAN KEMAL, SADRI SEVIL, ALBAYRAK CANAN, DEMIR AHMET MUZAFFER, GÜNER NIL, KEKLIK MUZAFFER, TERZI HATICE, DOGAN ALI, YEGIN ZEYNEP ARZU, YÜKSEL MELTEM, SADRI SOGOL, YAVASOGLU IRFAN, BEKÖZ HÜSEYIN SAFFET, AKSU TEKIN, MARAL SENEM, EROL VEYSEL, KAYNAR LEYLAGÜL, ILHAN OSMAN, BOLAMAN ALI ZAHIT, SEVINDIK ÖMÜR GÖKMEN, AKYAY ARZU, ÖZCAN MUHIT, GÜRMAN GÜNHAN, ÜNAL CANGÜL SULE, YAVUZ YASEMIN, DIZ KÜÇÜKKAYA REYHAN, ÖZSAN GÜNER HAYRI, Clinical Characteristics and Outcome of COVID-19 in Turkish Hematological Malignancy Patients, Turk J Haematol. 2022 Feb 23;39(1):43-54. doi: 10.4274/tjh.galenos.2021.2021.0287. (February 2022)

2
ATIF

A Novel Variant in the ACVRL1 Gene in a Patient with Cirrhosis and Hereditary Hemorrhagic Telangiectasia. Baysal M, Alkış N, Gürkan H, Demir AM.Turk J Haematol. 2021 Aug 25;38(3):241-243. doi: 10.4274/tjh.galenos.2021.2020.0749. Epub 2021 Mar 23. (August 2021)

.ATLI EMINE IKBAL, GÜRKAN HAKAN, ATLI ENGIN, YALÇINTEPE SINEM, DEMIR SELMA, EKER DAMLA, KALKAN RASIME, DEMIR AHMET MUZAFFER, Targeted massively parallel sequencing in the management of evaluated as cytogenetically normal lymphoid malignancies, J BUON ., vol. 26, no. 4, pp. 1540-1548, 2021.

.BAS VOLKAN,ÜMIT ELIF GÜLSÜM,KORKMAZ ÜLKÜ,BAYSAL MEHMET,KARAMAN GÜLSARAN SEDANUR,DEMIRCI UFUK,KIRKIZLAR HAKKI ONUR,ALTUN GÜLAY,DEMIR AHMET MUZAFFER, Sarcopenia in Hodgkin’s lymphoma evaluated with 18-FDG PET/CT, focus on age, performance, and treatment, SUPPORTIVE CARE IN CANCER, vol. 29, no. 5, pp. 2475-2480, 2021.

3
ATIF

.ATLI EMINE IKBAL, GÜRKAN HAKAN, KIRKIZLAR HAKKI ONUR, ATLI ENGIN, DEMIR SELMA, YALÇINTEPE SINEM, Kalkan R, DEMIR AHMET MUZAFFER, Pros and cons for fluorescent in situ hybridization, karyotyping and next generation sequencing for diagnosis and follow-up of multiple myeloma, Balkan Journal of Medical Genetics, vol. 23, no. 2, pp. 59-64, 2021.

.DEMIRCI UFUK, ÜMIT ELIF GÜLSÜM, DEMIR AHMET MUZAFFER, Increased Risk of e-Thrombosis in e-Life Era., Clin Appl Thromb Hemost, vol. 27, pp. 1-2, 2021.

.BAYSAL MEHMET, BAS VOLKAN, DEMIRCI UFUK, KARAMAN GÜLSARAN SEDANUR, ÜMIT ELIF GÜLSÜM, KIRKIZLAR HAKKI ONUR, DEMIR AHMET MUZAFFER, The Utility of CONUT Score in Diffuse Large B Cell Lymphoma Patients., Niger J Clin Pract, vol. 24, no. 8, pp. 1194-1199, 2021.

5
ATIF

ATIFLAR

Zhang, Yijing; Chen, Qiuni; Lu, Chuanyang; Yu, Liang. Prognostic role of controlling nutritional status score in hematological malignancies. HEMATOLOGY (December 2022)
Liu, TingTing; Hu, RenZhi; Lv, Jing; Luo, Qin; Xu, LuXiang; Wang, ChaoYu; Liu, Jun; Yang, ZaiLin; Xu, LingLi; Liu, Yao. Prognostic value of nutritional status in patients with human immunodeficiency virus infection-related lymphoma. FRONTIERS IN NUTRITION (November 2022)
Une, Minami; Ito, Masaya; Suzuki, Hiroaki; Toide, Masahiro; Kobayashi, Shuichiro; Fukushima, Hiroshi; Koga, Fumitaka. Controlling Nutritional Status (CONUT) Score and Sarcopenia as Mutually Independent Prognostic Biomarkers in Advanced Urothelial Carcinoma. CANCERS (October 2022)
Lu, Chuanyang; Chen, Qiuni; Fei, Linrong; Wang, Junhui; Wang, Chunling; Yu, Liang. Prognostic impact of the controlling nutritional status score in patients with hematologic malignancies: A systematic review and meta-analysis. (October 2022)
The Value of Prognostic Nutritional Index (PNI) on Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients: A Multicenter Retrospective Study of HHLWG Based on Propensity Score Matched Analysis Shen, ZY; Wang, F; (...); Sang, W 2021 | JOURNAL OF INFLAMMATION RESEARCH 14 , pp.5513-5522 (November 2021)

.BAYSAL MEHMET, ÜMIT ELIF GÜLSÜM, KIRKIZLAR HAKKI ONUR, DEMIR AHMET MUZAFFER, Comparison of Clinical Scoring Systems in the Management of Patients with Microangiopathic Hemolytic Anemia and Thrombocytopenia, Turkish Journal of Hematology, vol. 38, no. 1, pp. 64-68, 2021.

.ATLI EMINE IKBAL, GÜRKAN HAKAN, Atli E, KIRKIZLAR HAKKI ONUR, YALÇINTEPE SINEM, DEMIR SELMA, DEMIRCI UFUK, Eker D, Mail C, Kalkan R, DEMIR AHMET MUZAFFER, THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES , Mediterranean Journal of Hematology and Infectious Diseases, vol. 13, no. 1, pp. 1-10, 2021.

4
ATIF

ATIFLAR

Polprasert, Chantana; Kongkiatkamon, Sunisa; Niparuck, Pimjai; Rattanathammethee, Thanawat; Wudhikarn, Kitsada; Chuncharunee, Suporn; Kobbuaklee, Sirorat; Suksusut, Amornchai; Lanamtieng, Theerin; Lawasut, Panisinee; Asawapanumas, Thiti; Bunworasate, Udomsak; Rojnuckarin, Ponlapat. Genetic mutations associated with blood count abnormalities in myeloid neojiasms. HEMATOLOGY (December 2022)
Polprasert, Chantana; Niparuck, Pimjai; Rattanathammethee, Thanawat; Kobbuaklee, Sirorat; Lanamtieng, Theerin; Rojnuckarin, Ponlapat. Comparison of Molecular International Prognostic Scoring System (M-IPSS) and Revised International Prognostic Scoring System (R-IPSS) in Thai patients with myelodysplastic neoplasms. HEMATOLOGY (December 2022)
Polprasert, Chantana; Niparuck, Pimjai; Rattanathammethee, Thanawat; Chuncharunee, Suporn; Kobbuaklee, Sirorat; Songserm, Kritanan; Suksusut, Amornchai; Trithiphen, Sasinipa; Lanamtieng, Theerin; Kongkiatkamon, Sunisa; Chanswangphuwana, Excellent Prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related Mutations. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (May 2022)
Analytical validation and performance characteristics of a 48-gene next-generation sequencing panel for detecting potentially actionable genomic alterations in myeloid neoplasms Rosenthal, SH; Gerasimova, A; (...); Lacbawan, F Apr 28 2021 | PLOS ONE 16 (4) (April 2021)

.ATLI EMINE IKBAL,GÜRKAN HAKAN,DEMIR AHMET MUZAFFER, An unknown chromosomal aberration in a patient with chronic lymphocytic leukemia: Extra isochromosome 4q, Journal of Cancer Research and Therapeutics, vol. 17, no. 1, pp. 282-287, 2021.

Chronic myeloid leukaemia after chemoradiotherapy for solid malignancies. Baysal M, Ulutas G, Gokyer A, Umit E, Atli EI, Kirkizlar O, Gürkan H, Demir AM.Natl Med J India. 2020 Nov-Dec;33(6):347-348. doi: 10.4103/0970-258X.321138. (January 2020)

.G. E. ÜMIT, Ü. KORKMAZ, M. BAYSAL, S. G. KARAMAN, V. BAS, U. DEMIRCI, O. H. KIRKIZLAR, G. ALTUN, M. A. DEMIR, Evaluation of Sarcopenia with F-18 FDG PET/CT and relation with disease outcomes in patients with multiple myeloma, European Journal of Cancer Care, vol. 29, no. 6, 11, 2020.

1
ATIF

.M. BAYSAL, Y. ORTABURUN, R. A. SOYLU, A. M. YiLMAZTEPE, S. BAYSAL, G. E. ÜMIT, C. H. ÜMIT, A. H. TEZEL, M. A. DEMIR, Autonomic and diastolic dysfunction association with quality of life impairment in cirrhotic patients, Arab Journal of Gastroenterology, vol. 21, no. 1, pp. 32-36, 3, 2020.

.M. BAYSAL, U. DEMIRCI, V. BAS, S. G. KARAMAN, G. E. ÜMIT, O. H. KIRKIZLAR, S. BAYSAL, M. A. DEMIR, Could ratio of hemoglobin to red cell distribution width and ratio of absolute lymphocyte count to absolute monocyte count be a prognostic tool in newly diagnosed multiple myeloma patients?, Acta Haematologica Polonica, vol. 51, no. 2, pp. 81-87, 6, 2020.

.U. DEMIRCI, G. E. ÜMIT, M. A. DEMIR, A comment on “a prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia” by Zhou et al, American Journal of Hematology, 2, 2020.

.O. H. KIRKIZLAR, T. K. ALP, G. E. ÜMIT, I. ASKER, M. BAYSAL, V. BAS, S. G. KARAMAN, U. DEMIRCI, M. A. DEMIR, The Incidence of Venous Thromboembolism and Impact on Survival in Hodgkin Lymphoma, Clinical Lymphoma Myeloma and Leukemia, vol. 20, no. 8, pp. 542-547, 8, 2020.

4
ATIF

.R. DURAN, Ü. VATANSEVER, A. B. ACUNAS, B. ORHANER, M. A. DEMIR, ransient leukoerythroblastosis in a very low birth weight infant with parvovirus B19 infection., Int J Infect Dis, vol. 13, no. 6, pp. 473-475, 2020.

.S. G. KARAMAN, M. BAYSAL, U. DEMIRCI, V. BAS, O. H. KIRKIZLAR, G. E. ÜMIT, M. A. DEMIR, Late onset left ventricular dysfunction and cardiomyopathy induced with ibrutinib, Journal of Oncology Pharmacy Practice, vol. 26, no. 2, pp. 478-480, 3, 2020.

1
ATIF

.C. H. ÜMIT, G. ÜNSAL, A. H. TEZEL, R. A. SOYLU, E. G. PAMUK, B. TURGUT, M. A. DEMIR, D. TUCEL, N. ERMANTAS, U. ÇEVIKBAS, Vanishing bile duct syndrome in a patient with Hodgkin’xxs lymphoma and asymptomatic hepatitis B virus infection., Acta Gastroenterol Belg, vol. 72, no. 2, pp. 277-278, 6, 2020.

.U. DEMIRCI, H. ÖZDEMIR, G. E. ÜMIT, D. K. DEMIRBAG, M. A. DEMIR, Reducing the Risk of Venous Thrombosis During Self-Isolation and COVID-19 Pandemic for Patients With Cancer: Focus on Home Exercises Prescription, Clinical and Applied Thrombosis/Hemostasis, vol. 26, pp. 107602962093394-, 1, 2020.

2
ATIF

.M. BAYSAL, U. DEMIRCI, G. E. ÜMIT, O. H. KIRKIZLAR, I. E. ATLI, H. GÜRKAN, S. G. KARAMAN, V. BAS, Ç. MAIL, M. A. DEMIR, Concepts of Double Hit and Triple Hit Disease in Multiple Myeloma, Entity and Prognostic Significance, Scientific Reports, vol. 10, no. 1, 12, 2020.

15
ATIF

ATIFLAR

Singh, C; Panakkal, V; Sreedharanunni, S; Jandial, A; Jain, A; Lad, D; Prakash, G; Khadwal, A; Malhotra, P. Presentation and Impact of Double and Triple hit Cytogenetics in Patients With Multiple Myeloma in the Real World. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (August 2022)
Kuan, JW; Chai, SL; Rajadurai, P; Lau, LG; Uchang, J; Husain, SNAS. A Case Report of Leptomeningeal Myelomatosis and Rapid Improvement with Regimen Consisting of Daratumumab, Pomalidomide, Vincristine, Procarbazine, and Dexamethasone. CASE REPORTS IN HEMATOLOGY (August 2022)
Dragos, ML; Ivanov, IC; Mentel, M; Vacarean-Trandafir, IC; Sireteanu, A; Titianu, AA; Dascalescu, AS; Stache, AB; Jitaru, D; Gorgan, DL. Prognostic Value of Association of Copy Number Alterations and Cell-Surface Expression Markers in Newly Diagnosed Multiple Myeloma Patients. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (July 2022)
Nguyen-Khac, F; Bidet, A; Daudignon, A; Lafage-Pochitaloff, M; Ameye, G; Bilhou-Nabera, C; Chapiro, E; Collonge-Rame, MA; Cuccuini, W; Douet-Guilbert, N; Eclache, V; Luquet, I; Michaux, L; Nadal, N; Penther, D; Quilichini, B; Terre, C; Lefebvre, C; Troadec, MB; Veronese, L. The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH). LEUKEMIA (June 2022)
Cerchione, C; Usmani, SZ; Stewart, AK; Kaiser, M; Rasche, L; Kortuem, M; Mateos, MV; Spencer, A; Sonneveld, P; Anderson, KC. Gene Expression Profiling in Multiple Myeloma: Redefining the Paradigm of Risk-Adapted Treatment. FRONTIERS IN ONCOLOGY (February 2022)
Chromosomal 1q21 abnormalities in multiple myeloma: a review of translational, clinical research, and therapeutic strategies Bisht, K; Walker, B; (...); van de Velde, H Dec 2 2021 | Oct 2021 (Early Access) | EXPERT REVIEW OF HEMATOLOGY 14 (12) , pp.1099-1114 (December 2021)
Plasma cell leukemia: A review of the molecular classification, diagnosis, and evidenced-based treatment Gowin, K; Skerget, S; (...); Cowan, AJ Dec 2021 | LEUKEMIA RESEARCH 111 (December 2021)
Lenalidomide, bortezomib and dexamethasone followed by tandem-autologous stem cell transplantation is an effective treatment modality for multi-hit multiple myeloma Tang, SH; Lu, Y; (...); Pei, RZ Nov 2021 | LEUKEMIA RESEARCH 110 (November 2021)
Impact of t(11;14) as a sole and concomitant abnormality on outcomes in multiple myeloma Bal, S; Giri, S; (...); Costa, LJ Oct 2021 | Jun 2021 (Early Access) | BRITISH JOURNAL OF HAEMATOLOGY 195 (1) , pp.112-E116 (October 2021)
Case series: MRD negativity assessment using C-11-Acetate PET with 3-weekly daratumumab-based quadruplet induction in newly diagnosed multiple myeloma Ngai, C; Kumar, S; (...); Chim, CS Sep 2021 | THERAPEUTIC ADVANCES IN HEMATOLOGY 12 (September 2021)
A Comprehensive Review of the Genomics of Multiple Myeloma: Evolutionary Trajectories, Gene Expression Profiling, and Emerging Therapeutics Awada, H; Thapa, B; (...); Dhakal, B Aug 2021 | CELLS 10 (8) (August 2021)
Autologous peripheral blood stem cell transplantation as front-line therapy for myeloma with double-hit and triple-hit in a real-world study Yang, GZ; Wang, GR; (...); Chen, WM Aug 20 2021 | CHINESE MEDICAL JOURNAL 134 (16) , pp.1991-1993 (August 2021)
Malignant plasmacytes in bone marrow detected by flow cytometry as a predictor for the risk stratification system of multiple myeloma Tian, MY; Liu, ZY; (...); Fu, R May 2021 (Early Access) | CYTOMETRY PART B-CLINICAL CYTOMETRY (May 2021)
Novel dual LSD1/HDAC6 inhibitors for the treatment of multiple myeloma Sadhu, MN; Sivanandhan, D; (...); Rajagopal, S Feb 15 2021 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 34 (February 2021)
Genetic Predictors of Mortality in Patients with Multiple Myeloma Hassan, H and Szalat, R 2021 | APPLICATION OF CLINICAL GENETICS 14 , pp.241-254 (January 2021)

.M. BAYSAL, G. E. ÜMIT, O. H. KIRKIZLAR, M. A. DEMIR, Comparison of Clinical Scoring Systems in the Management of Patients with Microangiopathic Hemolytic Anemia and Thrombocytopenia, Turkish Journal of Hematology, 11, 2020.

Dominique Farge, Corinne Frere, Jean M Connors, Cihan Ay, Alok A Khorana, Andres Munoz, Benjamin Brenner, Ajay Kakkar, Hanadi Rafii, Susan Solymoss, Dialina Brilhante, Manuel Monreal, Henri Bounameaux, Ingrid Pabinger, James Douketis, Walter Ageno, Fernando Ajauro, Kamal R Al-Aboudi, Thierry Alcindor, Thierry Andre, Pantep Angchaisuksiri, Darko Antic, Juan I Arcelus, Eric Assenat, Kenneth A Bauer, Ali Bazarbachii, Ilham Benzidia, Jan Beyer-Westendorf, Viktoria Bitsadze, Dorit Blickstein, Mark Blostein, Isabel Bogalho, Barbara Bournet, Patricia Casais, Antoine F Carpentier, Gabriela Cesarman-Maus, Joydeep Chakbrabartty, Hugo Clemente, Jérôme Connault, Ludovic Doucet, Cécile Durant, Joseph Emmerich, Anna Falanga, Clemens Feistritzer, Carme Font, Charles Francis, Enrique Gallardo, Thomas Gary, Jean-Christophe Gris, Cecilia Guillermo, Adrian Hij, Russel D Hull, Takayuki IKezoe, Luis Jara-Palomares, Nigel S Key, Jamilya Khrizroeva, Maral Koolian, Florian Langer, Claire Le Hello, Ramón Lecumberri, Lai Heng Lee, Howard Liebman, Luisa Lopes Dos Santos, Duarte Henrique Machado, Isabelle Madelaine, Alexander Makatsariya, Mario Mandala, Anthony Marayevas, Zora Marjanovic, Christine Marosi, Ellis Martin, Luis Meillon, Emmanuel Messas, Antonio Moreira, Ahmet M Demir, Arlette Ndour, Michel Nguessan, Remedios Otero-Candelera, Vanessa Pachon Olmos, Ana Pais, Florian Posch, Matthias Preusser, Hanno Riess, Marc Righini, Cynthia Rothschild, Andre Roussin, José Antonio Rueda-Camino, Pedro Ruiz-Artacho, Sanjith Saseedharan, Ali Shamseddine, Gerald Soff, Hans Stricker, Vicky Tagalakis, Ali Taher, Toutou Toussaint, Javier Trujillo-Santos, Stéphane Villiers, Raymond Wong, Norizaku Yamada. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancerThe Lancet Oncology 2019; 20(10):e566-581.

4
ATIF

.G. E. ÜMIT, M. BAYSAL, V. BAS, A. ISMAIL, O. H. KIRKIZLAR, M. A. DEMIR, Polypharmacy and potentially inappropriate medication use in older patients with multiple myeloma, related to fall risk and autonomous neuropathy, JOURNAL OF ONCOLOGY PHARMACY PRACTICE, vol. 26, no. 1, pp. 43-50, 12, 2019.

7
ATIF

ATIFLAR

Gutierrez, NB; Ramallo, HR; Gonzalez, MF; Martin, LAK. Smartphone Apps for Patients With Hematologic Malignancies: Systematic Review and Evaluation of Content. JMIR MHEALTH AND UHEALTH (September 2022)
Malta, Jessica Soares; de Miranda Drummond, Paula Lana; Silveira, Livia Pena; Costa, Naiane Lima; Marques dos Santos, Roberta Marcia; Machado, Carla Jorge; Moreira Reis, Adriano Max; Menezes de Padua, Cristiane Aparecida. Effect of therapeutic regimens and polypharmacy on health-related quality of life of people with multiple myeloma: a cross-sectional study in Belo Horizonte, Brazil. CURRENT MEDICAL RESEARCH AND OPINION (August 2022)
Lopes Machado, Taisa Roberta; Menezes de Padua, Cristiane Aparecida; de Miranda Drummond, Paula Lana; Silveira, Livia Pena; Malta, Jessica Soares; Marques dos Santos, Roberta Marcia; Costa, Naiane Lima; Moreira Reis, Adriano Max. Use of fall risk-increasing drugs in older adults with multiple myeloma: A cross-sectional study. JOURNAL OF GERIATRIC ONCOLOGY (May 2022)
Frailty assessment in the care of older people with haematological malignancies Goede, V; Neuendorff, NR; (...); Cordoba, R Nov 2021 | LANCET HEALTHY LONGEVITY 2 (11) , pp.E736-E745 (November 2021)
Inappropriate medications and physical function: a systematic review Manias, E; Kabir, MZ and Maier, AB Jul 2021 | THERAPEUTIC ADVANCES IN DRUG SAFETY 12 (July 2021)
Impact of Polypharmacy Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Older Adults Sugidono, M; Lo, MM; (...); Olin, RL Apr 2021 | TRANSPLANTATION AND CELLULAR THERAPY 27 (4) (April 2021)
Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders Markov, A; Thangavelu, L; (...); Hassanzadeh, A Mar 18 2021 | STEM CELL RESEARCH & THERAPY 12 (1) (March 2021)

.M. BAYSAL, G. E. ÜMIT, O. H. KIRKIZLAR, C. A. OZDOVER, M. A. DEMIR, Thalidomide for the Management of Bleeding Episodes in Patients with Hereditary Hemorrhagic Telangiectasia, Effects on Epistaxis Severity Score and Quality of Life, Turkish Journal of Hematology, 6, 2019.

7
ATIF

ATIFLAR

Viteri-Noel, Adrian; Gonzalez-Garcia, Andres; Patier, Jose Luis; Fabregate, Martin; Bara-Ledesma, Nuria; Lopez-Rodriguez, Monica; del Olmo, Vicente Gomez; Manzano, Luis. Hereditary Hemorrhagic Telangiectasia: Genetics, Pathophysiology, Diagnosis, and Management. JOURNAL OF CLINICAL MEDICINE (September 2022)
Al-Samkari, Hanny. Systemic Antiangiogenic Therapies for Bleeding in Hereditary Hemorrhagic Telangiectasia: A Practical, Evidence-Based Guide for Clinicians. SEMINARS IN THROMBOSIS AND HEMOSTASIS (July 2022)
Thi Thao Truc Le; Martinent, Guillaume; Dupuis-Girod, Sophie; Parrot, Antoine; Contis, Anne; Riviere, Sophie; Chinet, Thierry; Grobost, Vincent; Espitia, Olivier; Dussardier-Gilbert, Brigitte; Alric, Laurent; Armengol, Guillaume; Maillard, Helene; Leguy-. Development and validation of a quality of life measurement scale specific to hereditary hemorrhagic telangiectasia: the QoL-HHT. ORPHANET JOURNAL OF RARE DISEASES (July 2022)
Kasthuri, Raj S.; Chaturvedi, Shruti; Thomas, Sonia; Vandergrift, Nathan; Bann, Carla; Schaefer, Nicole; Clancy, Marianne S.; Pyeritz, Reed; McCrae, Keith R. Development and performance of a hereditary hemorrhagic telangiectasia-specific quality-of-life instrument. BLOOD ADVANCES (July 2022)
Al-Samkari, Hanny; Eng, Whitney. A precision medicine approach to hereditary hemorrhagic telangiectasia and complex vascular anomalies. JOURNAL OF THROMBOSIS AND HAEMOSTASIS (May 2022)
Long-term efficacy assessment of current treatment options for epistaxis in HHT Dur, C; Anschuetz, L; (...); Caversaccio, M Nov 2021 | Mar 2021 (Early Access) | EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY 278 (11) , pp.4321-4328 (November 2021)
Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care Al-Samkari, H Feb 18 2021 | BLOOD 137 (7) , pp.888-895 (February 2021)

.G. E. ÜMIT, M. BAYSAL, O. H. KIRKIZLAR, M. A. DEMIR, Economic Analysis of Oral Posaconazole Prophylaxis in Acute Myeloid Leukemia During Remission Induction in Turkey, Northern Clinics of Istanbul, 1, 2019.

.D. ÇEKDEMIR, S. GÜVENÇ, F. ÖZDEMIRKiRAN, A. ESER, T. TOPTAS, V. ÖZKOCAMAN, H. S. HAYDAROGLU, E. T. ERMIS, R. ESER, M. CÖMERT, S. SADRI, M. ASLANER, B. U. UNCU, A. KARAKUS, D. B. SELIM, I. ALACACIOGLU, D. AYDiN, A. TEKINALP, S. NAMDAROGLU, F. CERAN, P. TARKUN, D. H. Ü. KIPER, M. ÇETINER, N. M. YENEREL, M. A. DEMIR, G. YILMAZ, H. TERZI, E. ATILLA, Y. Ü. MALKAN, K. ACAR, E. ÖZTÜRK, A. TOMBAK, C. SUNU, O. SALIM, N. ALAYVAZ, Ö. SAYAN, Ü. OZAN, M. AYER, Z. GÖKGÖZ, N. ANDIÇ, E. KiZiLKiLiÇ, F. NOYAN, M. ÖZEN, F. T. PEPEDIL, G. E. ALANOGLU, A. H. ÖZKAN, V. ASLAN, G. ÇETIN, A. AKYOL, B. DEVECI, F. D. ERSOY, H. DERMENCI, P. AYTAN, M. GUNDUZ, V. KARAKUS, C. OZLU, S. DEMIRCIOGLU, A. M. O. YANAR, D. ÖZATLI, L. ÜNDAR, N. E. TIFTIK, G. A. S. TÜRKÖZ, C. I. HAZNEDAROGLU, M. ÖZCAN, M. SENCAN, M. TOMBULOGLU, G. ÖZET, O. BILGIR, B. TURGUT, A. M. ÖZCAN, B. K. PAYZIN, M. SÖNMEZ, O. M. AYYILDIZ, S. M. DAL, S. ERTOP, M. TURGUT, T. SOYSAL, E. KAYA, A. ÜNAL, M. PEHLIVAN, I. ATAGUNDUZ, T. A. TUGLULAR, G. SAYDAM, R. K. DIZ, A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience, Turkish Journal of Hematology, vol. 36, no. 4, pp. 230-237, 9, 2019.

6
ATIF

ATIFLAR

Song, Andrew B.; Al-Samkari, Hanny. An updated evaluation of avatrombopag for the treatment of chronic immune thrombocytopenia. EXPERT REVIEW OF CLINICAL IMMUNOLOGY (August 2022)
Gomez-Almaguer, David; Rojas-Guerrero, Edgar A.; Gomez-De Leon, Andres; Colunga-Pedraza, Perla R.; Jaime-Perez, Jose C.Alternatives for managing patients with newly diagnosed immune thrombocytopenia: a narrative review. EXPERT REVIEW OF HEMATOLOGY (June 2022)
Aslaner, A. K. Muzeyyen; Sahip, Birsen. Quadruple Therapy in Patients with Immune Thrombocytopenia. KONURALP TIP DERGISI
Efficacy and safety of thrombopoietin receptor agonists in the treatment of thrombocytopenia after hematopoietic stem cell transplantation: a meta-analysis and systematic review Yao, YF; Tang, YQ; (...); Han, Y Nov 2 2021 | Dec 2021 (Early Access) | EXPERT REVIEW OF HEMATOLOGY 14 (11) , pp.1041-1048 (November 2021)
Efficiency and safety of eltrombopag for multi-line failed Chinese patients with immune thrombocytopenia: cases with decreased megakaryocyte response well from single-center experience Liu, Q; Shen, YY; (...); Wu, DJ Oct 2021 (Early Access) | IMMUNOLOGIC RESEARCH (October 2021)
Eltrombopag Effectiveness and Tolerability in Chronic Immune Thrombocytopenia: A Meta-Analysis Ahmed, HAW; Masoud, AT; (...); Sun, K Apr 19 2021 | CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS 27 (April 2021)

.D. FARGE, C. FRERE, M. J. CONNORS, C. AY, A. A. KHORANA, A. MUNOZ, B. BRENNER, A. KAKKAR, H. RAFII, S. SOLYMOSS, D. BRILHANTE, M. MONREAL, H. BOUNAMEAUX, I. PABINGER, J. DOUKETIS, W. AGENO, F. AJAURO, R. K. AL-ABOUDI, T. ALCINDOR, T. ANDRE, P. ANGCHAISUKSIRI, D. ANTIC, I. J. ARCELUS, E. ASSENAT, A. K. BAUER, A. BAZARBACHII, I. BENZIDIA, J. BEYER-WESTENDORF, V. BITSADZE, D. BLICKSTEIN, M. BLOSTEIN, I. BOGALHO, B. BOURNET, P. CASAIS, F. A. CARPENTIER, G. CESARMAN-MAUS, J. CHAKBRABARTTY, H. CLEMENTE, J. CONNAULT, L. DOUCET, C. DURANT, J. EMMERICH, A. FALANGA, C. FEISTRITZER, C. FONT, C. FRANCIS, E. GALLARDO, T. GARY, J. GRIS, C. GUILLERMO, A. HIJ, D. R. HULL, T. IKEZOE, L. JARA-PALOMARES, S. N. KEY, J. KHRIZROEVA, M. KOOLIAN, F. LANGER, C. H. LE, H. L. LEE, H. LIEBMAN, S. D. LOPES, H. D. MACHADO, I. MADELAINE, A. MAKATSARIYA, M. MANDALA, A. MARAYEVAS, Z. MARJANOVIC, C. MAROSI, E. MARTIN, L. MEILLON, E. MESSAS, A. MOREIRA, M. A. DEMIR, A. NDOUR, M. NGUESSAN, R. OTERO-CANDELERA, V. O. PACHON, A. PAIS, F. POSCH, M. PREUSSER, H. RIESS, M. RIGHINI, C. ROTHSCHILD, A. ROUSSIN, R. A. JOSÉ, P. RUIZ-ARTACHO, S. SASEEDHARAN, A. SHAMSEDDINE, G. SOFF, H. STRICKER, V. TAGALAKIS, A. TAHER, T. TOUSSAINT, J. TRUJILLO-SANTOS, S. VILLIERS, R. WONG, N. YAMADA, 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, The Lancet Oncology, vol. 20, no. 10, pp. 566-581, 10, 2019.

.M. BAYSAL, S. DEMIR, G. E. ÜMIT, H. GÜRKAN, V. BAS, S. G. KARAMAN, U. DEMIRCI, O. H. KIRKIZLAR, M. A. DEMIR, Genetic Diagnosis of Hereditary Hemorrhagic Telangiectasia: Four Novel Pathogenic Variations in Turkish Patients, Balkan Medical Journal, vol. 37, pp. 43-46, 12, 2019.

1
ATIF

.I. KOZANOGLU, T. PATIROGLU, K. DALVA, G. DEMIREL, T. SOYSAL, M. A. DEMIR, Results of the Haematology Laboratory Survey: What has changed in 8 years?, Turkish Journal of Hematology, 4, 2018.

.B. AYGEN, M. A. DEMIR, M. GÜMÜS, O. KARABAY, S. KAYMAKOGLU, S. A. KOKSAL, I. KOKSAL, N. ORMECI, F. Ö. TABAK, Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report, Turkish Journal of Gastroenterology, vol. 29, pp. 259-269, 10, 2018.

7
ATIF

ATIFLAR

Shin, SH; Park, SH. Viral Hepatitis in Patients with Inflammatory Bowel Disease. KOREAN JOURNAL OF GASTROENTEROLOGY (August 2022)
Baroiu, L; Anghel, L; Tatu, AL; Iancu, AV; Dumitru, C; Lese, AC; Draganescu, M; Nastase, F; Niculet, E; Fotea, S; Nechita, A; Voinescu, DC; Stefanopol, AI. Risk of hepatitis B reactivation: From biologic therapies for psoriasis to immunosuppressive therapies for COVID-19 (Review). EXPERIMENTAL AND THERAPEUTIC MEDICINE (June 2022)
Akar, SS; Sonmez, U; Demirdal, T; Sen, P; Ozer, D; Atalay, S; Akyol, D; Mermutluoglu, C; Celen, MK; Yamazhan, T; Pullukcu, H. Tenofovir alafenamid prophylaxis for the prevention of HBV reactivation in immunosuppressed subjects: a multicenter study. CUKUROVA MEDICAL JOURNAL
Asociacion Mexicana de Hepatologia A.C. Clinical guideline on hepatitis B Higuera-De-la-Tijera, F; Castro-Narro, GE; (...); Wolpert-Barraza, E Oct-dec 2021 | REVISTA DE GASTROENTEROLOGIA DE MEXICO 86 (4) , pp.403-432 (October 2021)
Evaluation of Hepatitis B screening and reactivation in patients receiving rituximab containing chemotherapy: A single-centre study Bozkurt, I; Cerik, HO; (...); Esen, S Aug 2021 (Early Access) | INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (August 2021)
Management of hepatitis B virus infection in patients with inflammatory bowel disease under immunosuppressive treatment Axiaris, G; Zampeli, E; (...); Bamias, G Jul 7 2021 | WORLD JOURNAL OF GASTROENTEROLOGY 27 (25) , pp.3762-3779 (July 2021)
A PRACTICAL ALGORITHM FOR NON-HEPATOLOGISTS TO PREVENT HEPATITIS B REACTIVATION RELATED TO IMMUNOSUPPRESSIVE TREATMENT AND CHEMOTHERAPY Ulasoglu, C 2021 | ACTA MEDICA MEDITERRANEA 37 (6) , pp.3141-3146

.G. E. ÜMIT, M. BAYSAL, M. A. DEMIR, Frailty in patients with acute myeloid leukaemia, conceptual misapprehension of chronological age, EUROPEAN JOURNAL OF CANCER CARE, vol. 27, no. 2, pp. 12810-, 3, 2018.

5
ATIF

ATIFLAR

Petrov, Dmitriy; Timilshina, Narhari; Papadopoulos, Efthymios; Alibhai, Shabbir M. H.Performance of the frailty index in predicting complete remission, intensive care unit admission, and overall mortality in older and younger patients with acute myeloid leukemia receiving intensive chemotherapy. LEUKEMIA & LYMPHOMA (July 2022)
Implementation of geriatric haematology programmes for the treatment of older people with haematological malignancies in low-resource settings Soto-Perez-de-Celis, E; Martinez-Peromingo, J; (...); Cordoba, R Nov 2021 | LANCET HEALTHY LONGEVITY 2 (11) , pp.E754-E763 (November 2021)
Frailty assessment in the care of older people with haematological malignancies Goede, V; Neuendorff, NR; (...); Cordoba, R Nov 2021 | LANCET HEALTHY LONGEVITY 2 (11) , pp.E736-E745 (November 2021)
A simple test-based frailty index to predict survival among cancer patients with an unplanned hospitalization: An observational cohort study Hembree, T; Theou, O; (...); Ramsakal, A Sep 2021 | Aug 2021 (Early Access) | CANCER MEDICINE 10 (17) , pp.5765-5774 (September 2021)
Identifying frailty in clinically fit patients diagnosed with hematological malignancies using a simple clinico-biological screening tool: The HEMA-4 study Thibaud, V; Deneve, L; (...); Bron, D Jul 2021 | JOURNAL OF GERIATRIC ONCOLOGY 12 (6) , pp.902-908 (July 2021)

.I. E. ATLI, H. GÜRKAN, M. A. DEMIR, An unknown chromosomal aberration in a patient with chronic lymphocytic leukemia: Extra isochromosome 4q, Journal of Cancer Research and Therapeutics, 12, 2018.

.V. ASOGLU, G. E. ÜMIT, M. A. DEMIR, A biomarker and therapeutical target in immune thrombocytopenia: TNF receptor-associated factor 6, Biomarkers in Medicine, 12, 2018.

.M. BAYSAL, G. E. ÜMIT, F. SARiTAS, S. N. KODAL, M. A. DEMIR, Drug Induced Thrombotic Microangiopathy with Certolizumab Pegol, Balkan Medical Journal, vol. 35, no. 5, pp. 398-399, 9, 2018.

1
ATIF

.M. BAYSAL, G. E. ÜMIT, B. I. BOZ, O. H. KIRKIZLAR, M. A. DEMIR, Fusarium Endophthalmitis, Unusual and Challenging Infection in an Acute Leukemia Patient, Case Reports in Hematology, vol. 2018, pp. 1-3, 1, 2018.

.E. Umit, M. Baysal, H. Kirkizlar, A. Demir, Splanchnic Venous Thrombosis, with Spotlight on Occult Malignancies, Anticoagulation, and Bleeding, 10.5152/EurJTher.2018.483, EUROPEAN JOURNAL OF THERAPEUTICS, vol. 24, no. 2, pp. 112-114, 2018.

.G. E. ÜMIT, M. BAYSAL, Y. DÜRMÜS, M. A. DEMIR, CD11c expression in chronic lymphocytic leukemia revisited, related with complications and survival, International Journal of Laboratory Hematology, vol. 39, no. 5, pp. 552-556, 10, 2017.

4
ATIF

.A. S. VARDAR, A. KARACA, S. GÜLDIKEN, O. PALABIYIK, N. SÜT, M. A. DEMIR, High-intensity interval training acutely alters plasma adipokine levels in young overweight/obese women, Archives of Physiology and Biochemistry, vol. 31, pp. 1-7, 8, 2017.

4
ATIF

ATIFLAR

Suzuki, K; Hekmatikar, AHA; Jalalian, S; Abbasi, S; Ahmadi, E; Kazemi, A; Ruhee, RT; Khoramipour, K. The Potential of Exerkines in Women's COVID-19: A New Idea for a Better and More Accurate Understanding of the Mechanisms behind Physical Exercise. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (December 2022)
Huminska-Lisowska, K; Mieszkowski, J; Kochanowicz, A; Bojarczuk, A; Niespodzinski, B; Brzezinska, P; Stankiewicz, B; Michalowska-Sawczyn, M; Grzywacz, A; Petr, M; Cieszczyk, P. Implications of Adipose Tissue Content for Changes in Serum Levels of Exercise-Induced Adipokines: A Quasi-Experimental Study. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (July 2022)
Ouerghi, N; Ben Fradj, MK; Duclos, M; Bouassida, A; Feki, M; Weiss, K; Knechtle, B. Effects of High-Intensity Interval Training on Selected Adipokines and Cardiometabolic Risk Markers in Normal-Weight and Overweight/Obese Young Males-A Pre-Post Test Trial. BIOLOGY-BASEL (June 2022)
Chen, PP; Jia, R; Liu, YY; Cao, MY; Zhou, L; Zhao, ZM. Progress of Adipokines in the Female Reproductive System: A Focus on Polycystic Ovary Syndrome. FRONTIERS IN ENDOCRINOLOGY (May 2022)

.U. S. MEHMET, P. E. GULSUM, M. MADEN, M. ELIF, C. GOKCEN, U. VESILE, U. G. ELIF, M. A. DEMIR, The impact of new generic formulations of imatinib mesylate on general quality of life in chronic phase chronic myeloid leukaemia patients, European Journal of Cancer Care, vol. 26, no. 2, 3, 2017.

1
ATIF

.G. E. ÜMIT, F. H. KULOGLU, M. A. DEMIR, Hypogammaglobulinemia and Poor Performance Status are Predisposing Factors for Vancomycin-Resistant Enterococcus Colonization in Patients with Hematological Malignancies, Turkish Journal of Hematology, vol. 34, no. 1, pp. 89-92, 3, 2017.

Prothrombin Complex Concentrates in Life-Threatening Bleeding. Sayhan MB, Salt Ö, Demir AM. Balkan Med J. 2016 Nov;33(6):712-713. (November 2016)

Is JAK2V617F Mutation the Only Factor for Thrombosis in Philadelphia-Negative Chronic Myeloproliferative Neoplasms? (September 2016)

Could the mosaic pattern of chromosomal abnormality predict overall survival of patients with myelodysplastic syndrome? Uyanik MS, Demir AM, Kurt I, Maden M, Oz Puyan F, Gurkan H, Umit EG, Pamuk GE. Hematol Oncol Stem Cell Ther. 2016 Jun;9(2):41-7. doi: 10.1016/j.hemonc.2015.12.002. (June 2016)

.S. M. UYANiK, M. BAYSAL, E. G. PAMUK, M. MADEN, A. MUSTAFA, U. G. ELIF, M. A. DEMIR, Is JAK2V617F Mutation the Only Factor for Thrombosis in Philadelphia Negative Chronic Myeloproliferative Neoplasms, Indian Journal of Hematology and Blood Transfusion, vol. 32, no. 3, pp. 262-267, -ALMANYA, 9, 2016.

.E. B. BILIR, S. GÜLDIKEN, N. TUNÇBILEK, M. A. DEMIR, A. POLAT, B. BILIR, The effects of fat distribution and some adipokines on insulin resistance, Endokrynol Pol., vol. 67, no. 3, pp. 277-282, 9, 2016.

2
ATIF

.M. ÇELIK, S. AYTÜRK, A. M. YILMAZTEPE, A. KÜÇÜKARDA, O. MERT, S. GÜLDIKEN, M. A. DEMIR, A. TUGRUL, Two Sisters with Gaucher Disease: Focus on the Effectiveness of Imiglucerase Treatment: Case Reports, British Journal of Medicine and Medical Research, vol. 17, no. 3, pp. 1-7, 1, 2016.

.R. DURAN, B. ORHANER, M. A. DEMIR, Factor VIII Levels in Children With Ischemic Stroke, Clinical and Applied Thrombosis/Hemostasis, vol. 13, no. 3, pp. 334-335, 6, 2016.

.S. M. UYANIK, M. A. DEMIR, I. KURT, M. MADEN, F. P. ÖZ, H. GÜRKAN, E. ÜMIT, E. G. PAMUK, Could the mosaic pattern of chromosomal abnormality predict overall survival of patients with myelodysplastic syndrome, Hematol Oncol Stem Cell Ther., vol. 9, no. 2, pp. 41-47, 6, 2016.

.B. M. SAYHAN, Ö. SALT, M. A. DEMIR, Prothrombin Complex Concentrates in Life Threatening Bleeding, Balkan Medical Journal, vol. 33, no. 6, pp. 712-713, EDIRNE-TÜRKIYE, 11, 2016.

The effects of fat distribution and some adipokines on insulin resistance. Endokrynol Pol. 2016;67(3):277-82. doi: 10.5603/EP.a2016.0023.

1
ATIF

Ongen G, Demir M, Molinas N, Ince B, Ongen Z. Evaluation of the Practice Pattern of Medical Patients' VTE Prophylaxis With a Standard Risk Assessment Model Form: MERAM Study. Clin Appl Thromb Hemost. 2015 Jul;21(5):412-9. (July 2015)

Koylu A, Pamuk GE, Uyanik MS, Demir M, Pamuk ON. Immune thrombocytopenia: epidemiological and clinical features of 216 patients in northwestern Turkey. Ann Hematol. 2015;94(3):459-66. (June 2015)

Pamuk GE, Ak R, Tasci M, Harmandar F, Demir M, Arican O. Clinical characteristics of haematological malignancy patients diagnosed with leukaemia cutis: Experience of a single centre. (May 2015)

Uras F, Küçük B, Bingöl-Özakpınar Ö, Demir AM. Growth Arrest-Specific 6 (Gas6) and TAM Receptors in Mouse Platelets. Turk J Hematol 2015, Turk J Hematol 2015;32:58-63 doi: 10.4274/tjh.2013.0097, pp 58-63 (March 2015)

2
ATIF

Akseki TH, Vardar SA, Demir M, Palabıyık O, Karaca A, Guksu Z, Ortanca A, Süt N. The alteration of NTproCNP plasma levels following anaerobic exercise in physically active young men. Anatol J Cardiol. 2015;15(2):97-102. (February 2015)

.P. E. GULSUM, R. AK, T. MURAT, H. FERDA, M. A. DEMIR, A. OZER, Clinical characteristics of haematological malignancy patients diagnosed with leukaemia cutis Experience of a single centre, Australasian Journal of Dermatology, vol. 56, no. 2, pp. 116-119, 5, 2015.

.K. AHMET, E. G. PAMUK, S. M. UYANIK, M. A. DEMIR, N. O. PAMUK, Immune thrombocytopenia epidemiological and clinical features of 216 patients in northwestern Turkey, Annals of Hematology, vol. 94, no. 3, pp. 459-466, -A.B.D. VIRJIN ADALARI, 3, 2015.

.G. YiLMAZ, S. ÜSTÜNDAG, O. TEMIZÖZ, N. SÜT, M. A. DEMIR, V. ERMIS, C. SEVINÇ, A. ÜSTÜNDAG, Fibroblast Growth Factor-23 and Carotid Artery Intima Media Thickness in Chronic Kidney Disease, Clinical Laboratory, vol. 61, no. 08/2015, pp. 1061-1070, 1, 2015.

.H. ÖNGEN, M. A. DEMIR, B. F. INCE, M. NIL, Z. ÖNGEN, Evaluation of the Practice Pattern of Medical Patients VTE Prophylaxis With a Standard Risk Assessment Model Form MERAM Study, Clinical and Applied Thrombosis/Hemostasis, vol. 21, no. 5, pp. 412-419, -AMERIKA BIRLESIK DEVLETLERI, 5, 2015.

.S. S. AYTÜRK, M. ÇELIK, O. MERT, A. Y. SEZER, S. GÜLDIKEN, M. A. DEMIR, Primary splenic diffuse large B cell lymphoma after splenectomy: A rare case with literatüre review., Am J Med Case Reports, vol. 3, no. 8, pp. 265-268, 2015.

.U. S. MEHMET, M. A. DEMIR, K. IDRIS, M. MADEN, P. O. FULYA, G. HAKAN, U. G. ELIF, E. G. PAMUK, Could the Mosaic Pattern of Chromosomal Abnormality Predict Overall Survival of Patients with Myelodysplastic Syndrome, Hematology/Oncology and Stem Cell Therapy, 1, 2015.

Clinical characteristics of haematological malignancy patients diagnosed with leukaemia cutis: Experience of a single centre. (November 2014)

Multiple Liver and Muscle Abscesses and Sepsis with Bacillus pantothenticus in a Leukemia Patient. (June 2014)

Akan H, Ongören Aydın S, Saltoğlu N, Cağatay A, Akalın H, Arat M, Ali R, Kalayoğlu-Beşışık S,Demir AM. Recommendations for the Treatment of Invasive Fungal Infections in Hematological Malignancies: A Critical Review of Evidence and Turkish Expert Opinion (TEO-1). Turk J Haematol. 2014;31(2):111-20. (March 2014)

.Ü. G. ELIF, Ü. C. HASAN, F. H. KULOGLU, M. A. DEMIR, Multiple Liver and Muscle Abscesses and Sepsis with Bacillus pantothenticus in a Leukemia Patient, Turkish Journal of Hematology, pp. 321-322, 9, 2014.

1
ATIF

.H. AKAN, Ö. S. AYDiN, N. SALTOGLU, A. A. ÇAGATAY, H. E. AKALIN, M. ARAT, R. ALI, K. S. BESiSiK, M. A. DEMIR, Recommendations for the Treatment of Invasive Fungal Infections in Hematological Malignancies A Critical Review of Evidence and Turkish Expert Opinion TEO 1, Turkish Journal of Hematology, vol. 31, no. 2, pp. 111-120, 6, 2014.

Pamuk GE, Ak R, Tasci M, Harmandar F, Demir M, Arican O. Clinical characteristics of haematological malignancy patients diagnosed with leukaemia cutis: Experience of a single centre. Australas J Dermatol. 2014 Nov 4. doi: 10.1111/ajd.12193. [Epub ahead of print]

Tekgündüz E, Demir M, Akyol Erikçi A, Akpınar S, Oztürk E, Kırkızlar O. Sticky platelet syndrome in patients with uninduced venous thrombosis. Turk J Haematol. 2013 Mar;30(1):48-52. (March 2013)

.E. I. A. TEKGÜNDÜZ, M. A. DEMIR, A. ERIKÇI, S. AKPINAR, E. ÖZTÜRK, O. KIRKIZLAR, Sticky platelet syndrome in patients with uninduced venous thrombosis, TURK J HEMATOL, vol. 30, pp. 48-52, 2013.

.S. FAHRI, S. GURAY, C. MELDA, B. UZ, S. A. YAVUZ, M. A. DEMIR, Turkish Chronic Myeloid Leukemia Study Retrospective Sectional Analysis of CML Patients, The Turkish Journal of Hematology, vol. 30, no. 4, pp. 351-358, 1, 2013.

.E. B. BILIR, S. N. ATILE, K. ONUR, Y. KÖMÜRCÜ, A. SEVAL, A. Y. SEZER, M. A. DEMIR, H. SEVIL, Effectiveness of preoperative plasmapheresis in a pregnancy complicated by hyperthyroidism and anti thyroid drug associated angioedema, Gynecological Endocrinology, vol. 29, no. 5, pp. 508-510, 5, 2013.

.Ö. Ö. BINGÖL, J. M. M. A. MAURER, C. ADIGÜZEL, M. A. DEMIR, F. URAS, Periferik kandan izole edilen hematopoietik kök hücrelerin megakaryosite farklilasmasi., Turk J Biochemistry, vol. 38, no. 3, pp. 243-248, 2013.

Effectiveness of preoperative plasmapheresis in a pregnancy complicated by hyperthyroidism and anti-thyroid drug-associated angioedema B Ekiz Bilir, N Soysal Atile, O Kirkizlar, Y Kömürcü, S Akpinar, A Sezer, ... Gynecological Endocrinology 29 (5), 508-510

Özakpınar ÖB, Maurer AM, Adıgüzel C, Çilingir ÖT, Demir M, Uras F. Periferik kandan izole edilen hematopoietik kök hücrelerin megakaryosite farklılaşması. Turk J Biochemistry 2013;38(3):243-248.

Pamuk G.E., Vural O., Turgut B., Demir M., Pamuk O.N., Cakir N. Increased platelet activation markers in rheumatoid arthritis: Are they related with subclinical atherosclerosis? (2008) Platelets, 19 (2) , pp. 146-154.

Guldiken B., Guldiken S., Demir M., Turgut N., Tugrul A. Low leptin levels in migraine: A case control study (2008) Headache, 48 (7) , pp. 1103-1107.

Guldiken B., Guldiken S., Demir M., Turgut N., Kabayel L., Ozkan H., Ozcelik E., Tugrul A. Insulin resistance and high sensitivity C-reactive protein in migraine (2008) Canadian Journal of Neurological Sciences, 35 (4) , pp. 448-451.

Guldiken B., Demir M., Guldiken S., Turgut N., Turgut B., Tugrul A. Oxidative stress and total antioxidant capacity in diabetic and nondiabetic acute ischemic stroke patients. (2009) Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 15 (6) , pp. 695-700.

Thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and activity assay in patients with primary hypothyroidism (2010) Clinical and Applied Thrombosis/Hemostasis, 16 (5) , pp. 568-573. Ermantas N., Guldiken S., Demir M., Tugrul A.

Sahin F, Saydam G, Cömert M, Uz B, Yavuz AS, Turan E, Yönal I, Atay H, Keltikli E, Turgut M, Pehlivan M, Akay MO, Gürkan E, Paydaş S, Kahraman S, Demirkan F, Kırkızlar O, Akpınar S, Pamuk GE, Demir M, Ozbaş HM, Sönmez M, Gültürk M, Salihoğlu A, Eşkazan AE, Ar C, Haydaroğlu Şahin H, Ongören S, Başlar Z, Aydın Y, Yenere MN, Tüzüner N, Ferhanoğlu B, Haznedaroglu IC, Ilhan O, Soysal T. Turkish Chronic Myeloid Leukemia Study: Retrospective Sectional Analysis of CML Patients. Turk J Haematol. 2013 Dec;30(4):351-8

Ekiz Bilir B, Soysal Atile N, Kirkizlar O, Kömürcü Y, Akpinar S, Sezer A, Demir M, Hekimoğlu S. Effectiveness of preoperative plasmapheresis in a pregnancy complicated by hyperthyroidism and anti-thyroid drug-associated angioedema. Gynecol Endocrinol. 2013; 29(5): 508-510

1
ATIF

.A. SENER, E. ENC, O. DERYA, V. BEN, G. YANIKKAYA-DEMIREL, O. RAS, F. URAS, M. A. DEMIR, Exogenous L Arginine and HDL Can Alter LDL and ox LDL Mediated Platelet Activation Using Platelet P Selectin Receptor Numbers, Clinical and Applied Thrombosis/Hemostasis, vol. 17, no. 6, pp. 79-86, 2, 2012.

.A. H. TEZEL, M. A. DEMIR, Inflammatory Bowel Disease and Thrombosis, Turkish Journal of Hematology, vol. 29, no. 2, pp. 111-119, 1, 2012.

.B. TASKIRAN, B. H. A. UGUR, A. S. VARDAR, M. A. DEMIR, H. Ç. KARADAG, A. ALTUN, Effect of exercise on ADMA level in type 2 diabetes mellitus., Balkan Med J., vol. 12, no. 1, pp. 62-67, 2012.

.T. HUSEYIN, C. UMRAN, M. A. DEMIR, Successful use of fondaparinux in a child with heparin induced thrombocytopenia, Blood Coagulation & Fibrinolysis, vol. 23, no. 8, pp. 769-771, 1, 2012.

.Ö. HÜSEYIN, E. G. PAMUK, N. Ö. PAMUK, M. A. DEMIR, B. TURGUT, Does anti tnf therapy cause any change in platelet activation in ankylosing spondylitis patients, Journal of Thrombosis and Thrombolysis, vol. 33, no. 2, pp. 154-159, 2, 2012.

Inflammatory bowel disease and thrombosis A Tezel, M Demir Turkish Journal of Hematology 29 (2), 111
1
ATIF
ATIFLAR
- Overview of Venous Thrombosis in Inflammatory Bowel Disease T Purnak, O Yuksel - Inflammatory bowel diseases, 2015 - journals.lww.com

Does anti-tnf therapy cause any change in platelet activation in ankylosing spondylitis patients? H Orüm, GE Pamuk, ON Pamuk, M Demir, B Turgut J Thromb Thrombolysis 33, 154-159

2
ATIF

.B. TURGUT, N. TURGUT, Y. ÇELIK, T. EMRE, E. G. PAMUK, M. A. DEMIR, Differences in platelet leukocyte aggregates among subtypes of acute cerebral ischemia, Journal of the Neurological Sciences, vol. 305, no. 1-2, pp. 126-130, 6, 2011.

.T. EMRE, M. A. DEMIR, A. A. ERIKCI, S. AKPINAR, O. ERMAN, K. ONUR, Sticky platelet syndrome in patients with unexplained venous thrombosis, Turkish Journal of Hematology, 10, 2011.

.K. ISiK, F. TÜLIN, T. TAYFUR, U. VAS, M. A. DEMIR, Low Levels of Protein Z Are Associated With HELLP Syndrome and its Severity, Clinical and Applied Thrombosis/Hemostasis, vol. 17, no. 2, pp. 214-219, 3, 2011.

.G. SIBEL, G. BABURHAN, M. A. DEMIR, L. KABAYEL, O. HULYA, N. TURGUT, H. REMZIYE, K. SELAHATTIN, Soluble CD40 ligand and prolactin levels in migraine patients during interictal period, The Journal of Headache and Pain, vol. 12, no. 3, pp. 355-360, 6, 2011.

.D. BURAK, T. ABDULLAH, M. A. DEMIR, Effect of the levels of vascular endothelial growth factor A and C on the prognosis of patients with larynx carcinoma, The Turkish Journal of Ear Nose and Throat, pp. 122-128, 5, 2011.

Low levels of protein Z are associated with HELLP syndrome and its severity I Kaygusuz, T Firatli-Tuglular, T Toptas, V Ugurel, M Demir Clinical and Applied Thrombosis/Hemostasis 17 (2), 214-219

1
ATIF

Soluble CD40 ligand and prolactin levels in migraine patients during interictal period S Guldiken, B Guldiken, M Demir, L Kabayel, H Ozkan, N Turgut, ... The journal of headache and pain 12 (3), 355-360

6
ATIF

ATIFLAR

Assessment of Metabolic Syndrome in Patients with Migraine in Central Anatolia A Celikbilek, E Borekci, M Kozan, M Celikbilek - Eur J Gen Med, 2015 - ejgm.org
The relationship between dry eye and migraine A Celikbilek, M Adam - Acta Neurologica Belgica, 2015 - Springer
Unraveling genetic mechanisms in headache syndromes CM Weller - 2015 - openaccess.leidenuniv.nl
Tumor Necrosis Factor (TNF)–308G> A, Nitric Oxide Synthase 3 (NOS3)+ 894G> T Polymorphisms and Migraine Risk: A Meta-Analysis M Chen, W Tang, L Hou, R Liu, Z Dong, X Han… - PloS one, 2015 - journals.plos.org
Vascular biomarkers in migraine GE Tietjen, J Khubchandani - Cephalalgia, 2015 - cep.sagepub.com
A simultaneous electrochemical multianalyte immunoassay of high sensitivity C-reactive protein and soluble CD40 ligand based on reduced graphene oxide- … G Yuan, C Yu, C Xia, L Gao, W Xu, W Li, J He - Biosensors and …, 2015 - Elsevier

Taskiran B, Guldiken S, Demir AM, Okman TK, Arikan E, Turgut B, Tugrul AA. Effect of obesity on TAFI in postmenopausal period. Obes Res Clin Pract. 2010;4(4):e247-342. (September 2010)

.N. ERMANTAS, S. GÜLDIKEN, M. A. DEMIR, A. TUGRUL, Thrombin -Activatable Fibrinolysis Inhibitor (TAFI) Antigen and Activity Assay in Patients With Primary Hypothyroidism., CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, vol. 16, no. 5, pp. 568-573, 2010.

.S. TETIK, K. KAYA, M. A. DEMIR, E. DEMIRALP, T. K. YARDIMCI, Oxidative Modification of Fibrinogen Affects Its Binding Activity to Glycoprotein (GP) IIb/IIIa., Clin Appl Thromb Hemost, vol. 16, no. 1, pp. 51-59, 2010.

.N. ERMANTAS, S. GÜLDIKEN, M. A. DEMIR, A. TUGRUL, Thrombin Activatable Fibrinolysis Inhibitor TAFI Antigen and Activity Assay in Patients With Primary Hypothyroidism, Clinical and applied Thrombosis/Hemostasis, vol. 16, no. 5, pp. 568-573, New York-AMERIKA BIRLESIK DEVLETLERI, 2010.

.E. ÖZTÜRK, E. G. PAMUK, B. TURGUT, F. P. ÖZ, M. A. DEMIR, Testicular Plasmacytoma: Case Report, Turkiye Klinikleri Journal of Medical Sciences, vol. 30, no. 1, pp. 430-434, 1, 2010.

.E. I. A. TEKGÜNDÜZ, M. A. DEMIR, S. AKPINAR, Acute Lymphoblastic Leukemia Prognostic Factors’xx Perspective. , UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi, vol. 20, no. 1, pp. 57-66, 2010.

.T. AKTOZ, M. AKTOZ, E. TATLI, M. KAPLAN, N. F. TURAN, A. BARUTÇU, H. I. ATAKAN, M. A. DEMIR, A. ALTUN, Assessment of the relationship between asymmetric dimethylarginine and severity of erectile dysfunction and coronary artery disease., Int Urol Nephrol, vol. 42, no. 4, pp. 873-879, 2010.

.A. Y. SEZER, N. TUNÇBILEK, S. GÜLDIKEN, M. A. DEMIR, E. M. IRFANOGLU, C. IBIS, The Risk of Venous Thromboembolism With Thyroid Surgery, The Endocrinologist, vol. 20, no. 5, pp. 236-239, 1, 2010.

.S. CETIN, C. OKAY, K. ISMAIL, A. HILAL, K. G. LEYLA, A. FEVZI, E. BULENT, M. A. DEMIR, C. MUSTAFA, O. YUSUF, Expression of WT1 gene in multiple myeloma patients at diagnosis is WT1 gene expression a useful marker in multiple myeloma, Hematology, vol. 15, no. 1, pp. 39-42, 2, 2010.

.E. G. PAMUK, M. TASÇI, E. ÖZTÜRK, M. A. DEMIR, Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII, Medical Oncology, vol. 27, no. 1, pp. 16-19, 3, 2010.

.E. G. PAMUK, N. Ö. PAMUK, H. ÖRÜM, M. A. DEMIR, B. TURGUT, N. ÇAKIR, Might platelet-leucocyte complexes be playing a role in major vascular involvement of Behçet’xxs disease? A comparative study. , Blood Coagul Fibrinol, vol. 21, no. 2, pp. 113-117, 2010.

.M. A. DEMIR, E. I. A. TEKGÜNDÜZ, Antithrombotic and Anticoagulant Usage Policies, Trakya Univ Tip Fak Derg, vol. 27, no. 1, pp. 69-73, Edirne-TÜRKIYE, 1, 2010.

.T. BENGUR, G. SIBEL, M. A. DEMIR, O. K. TULAY, A. ENDER, B. TURGUT, T. A. AYSE, Effect of obesity on TAFI in postmenopausal period, Obesity Research & Clinical Practice, vol. 4, no. 4, pp. 271-276, 10, 2010.

.E. E. ÇAKIR, N. O. HATIPOGLU, Y. IM, A. EKER, Ö. TANSEL, N. SÜT, E. I. A. TEKGÜNDÜZ, M. A. DEMIR, Hospital-acquired pneumonia in patients receiving immunosuppressive therapy. 2010 27(1):20-24., Turk J Hematol, vol. 27, no. 1, pp. 20-24, 2010.

.M. AKTOZ, T. AKTOZ, E. TATLI, M. KAPLAN, N. F. TURAN, A. BARUTÇU, H. I. ATAKAN, M. A. DEMIR, A. ALTUN, Asymmetrical dimethylarginine and severity of erectile dysfunction and their impact on cardiovascular events in patients with acute coronary syndrome. , Archives of Medical Science, vol. 6, no. 2, pp. 168-175, 2010.

Asymmetrical dimethylarginine and severity of erectile dysfunction and their impact on cardiovascular events in patients with acute coronary syndrome M Aktoz, T Aktoz, E TatlI, M Kaplan, FN Turan, A Barutçu, IH Atakan, ... Arch Med Sci 6 (2), 168-175

1
ATIF

Exogenous L-arginine and HDL can alter LDL and ox-LDL-mediated platelet activation: using platelet P-selectin receptor numbers A Sener, E Enc, D Ozsavci, B Vanizor-Kural, G Yanikkaya-Demirel, R Oba, ... Clinical and Applied Thrombosis/Hemostasis, 1076029610385223

1
ATIF

Oxidative modification of fibrinogen affects its binding activity to glycoprotein (GP) IIb/IIIa S Tetik, K Kaya, M Demir, E Eksioglu-Demiralp, T Yardimci Clinical and Applied Thrombosis/Hemostasis 16 (1), 51-59

1
ATIF

Might platelet-leucocyte complexes be playing a role in major vascular involvement of Behçet's disease? A comparative study GE Pamuk, ÖN Pamuk, H Örüm, M Demir, B Turgut, N Cakir Blood Coagulation & Fibrinolysis 21 (2), 113-117

1
ATIF

Assessment of the relationship between asymmetric dimethylarginine and severity of erectile dysfunction and coronary artery disease T Aktoz, M Aktoz, E Tatlı, M Kaplan, FN Turan, A Barutcu, IH Atakan, ... International urology and nephrology 42 (4), 873-879

3
ATIF

Antineutrophil cytoplasmic antibody associated vasculitis in one patient with severe aplastic anemia: description of the first case GE Pamuk, ÖN Pamuk, EG Ümit, FÖ Puyan, E Öztürk, M Demir Leukemia research 33 (8), e95-e97

1
ATIF

Transient leukoerythroblastosis in a very low birth weight infant with parvovirus B19 infection R Duran, Ü Vatansever, B Acunaş, B Orhaner, M Demir International Journal of Infectious Diseases 13 (6), e473-e475

1
ATIF

The first case of de novo B-cell prolymphocytic leukemia with central nervous system involvement: description of an unreported complication GE Pamuk, FÖ Puyan, E Ünlü, E Öztürk, M Demir Leukemia research 33 (6), 864-867

1
ATIF

Short term effects of GnRH agonists on plasma fibrinolytic balance in patients with advanced prostate cancer M Agirbasli, OA Baykan, A Tekin, F Sengor, AA Cincin, M Demir, ... Journal of thrombosis and thrombolysis 27 (2), 172-174

1
ATIF

Asymmetric dimethylarginine and nitric oxide levels in migraine during the interictal period B Guldiken, M Demir, S Guldiken, N Turgut, H Ozkan, L Kabayel, A Tugrul Journal of Clinical Neuroscience 16 (5), 672-674

5
ATIF

European community and US-FDA approval of recombinant human antithrombin produced in genetically altered goats C Adiguzel, O Iqbal, M Demir, J Fareed Clinical and Applied Thrombosis/Hemostasis 15 (6), 645-651

1
ATIF

Systemic and topical fresh-frozen plasma treatment in a newborn with ligneous conjunctivitis. By: Gürlü, Vuslat Pelitli; Demir, Muzaffer; Alimgil, M Levent; et al. Cornea Volume: 27 Issue: 4 Pages: 501-3 Published: 2008-May (May 2008)

The relationship between proinflammatory cytokine levels and fibrinolytic system in obese patients M Gerenli, A Tuğrul, M Demir, E Arıkan, S GÜLDİKEN, Ş Azcan Balkan Medical Journal 2008 (1)

1
ATIF

Oxidative stress and total antioxidant capacity in diabetic and nondiabetic acute ischemic stroke patients B Guldiken, M Demir, S Guldiken, N Turgut, B Turgut, A Tugrul Clinical and Applied Thrombosis/Hemostasis

1
ATIF

Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged? J Fareed, O Iqbal, J Cunanan, M Demir, R Wahi, M Clarke, C Adiguzel, ... International Angiology 27 (3), 176

2
ATIF

Systemic and topical fresh-frozen plasma treatment in a newborn with ligneous conjunctivitis VP Gürlü, M Demir, ML Alimgil, S Erda Cornea 27 (4), 501-503

6
ATIF

ATIFLAR

Lignöz Konjonktivit İ Sibel - Kocatepe Tıp Dergisi, 2015 - dergipark.ulakbim.gov.tr
Response of Plasminogen Deficiency Associated Ligneous Conjunctivitis to Topical Fresh frozen Plasma with Heparin SC Putri, NR La Distia, S Made - Journal of Case Reports, 2015 - casereports.in
Ligneous conjunctivitis in a patient of juvenile colloid milia: A rare association SS Bhave, SS Joshi - Indian journal of ophthalmology, 2015 - ncbi.nlm.nih.gov
A Puzzling Case: Hypoplasminogenemia, Ligneous Conjunctivitis and Hydrocephalus E Karadag-Oncel, AB Cengiz, D Orhan… - Pediatric hematology …, 2015 - Taylor & Francis
Successful treatment of ligneous conjunctivitis with topical fresh frozen plasma in an infant ZÖ Tunay, Ö Özdemir, D Acar, S Akbay - Arquivos brasileiros de …, 2015 - SciELO Brasil
Ligneous Cervicovaginitis Associated with Plasminogen Deficiency: A Rare Cause of Infertility A Akdogan, G Sahin, L Akman, D Simsek… - UHOD-ULUSLARARASI …, 2015 - thod.org

EORTC QLQ-C30 assessment in Turkish patients with hematological malignancies GE Pamuk, F Harmandar, N Ermantaş, O Harmandar, B Turgut, M Demir, ... Annals of hematology 87 (4), 305-310

2
ATIF

The roles of oxidized low-density lipoprotein and interleukin-6 levels in acute atherothrombotic and lacunar ischemic stroke B Guldiken, S Guldiken, B Turgut, N Turgut, M Demir, Y Celik, E Arikan, ... Angiology

1
ATIF

Insulin resistance and high sensitivity C-reactive protein in migraine B Guldiken, S Guldiken, M Demir, N Turgut, L Kabayel, H Ozkan, ... The Canadian Journal of Neurological Sciences 35 (04), 448-451

6
ATIF

ATIFLAR

Supplementation with Riboflavin (Vitamin B N Namazi, J Heshmati… - Int. J. Vitam. Nutr. …, 2015 - econtent.hogrefe.com
High sensitivity C-reactive protein and cerebral white matter hyperintensities on magnetic resonance imaging in migraine patients AY Avci, H Lakadamyali, S Arikan… - The journal of …, 2015 - biomedcentral.com
Migraine and body mass index categories: a systematic review and meta-analysis of observational studies R Ornello, P Ripa, F Pistoia, D Degan, C Tiseo… - J Headache …, 2015 - biomedcentral.com
Vascular biomarkers in migraine GE Tietjen, J Khubchandani - Cephalalgia, 2015 - cep.sagepub.com
Endothelial Function in Migraine With Aura–A Systematic Review JH Butt, U Franzmann, C Kruuse - Headache: The Journal of …, 2015 - Wiley Online Library
Migraine and obesity: metabolic parameters and response to a weight loss programme A Verrotti, M Carotenuto, L Altieri, P Parisi… - Pediatric …, 2015 - Wiley Online Library

Low leptin levels in migraine: a case control study B Guldiken, S Guldiken, M Demir, N Turgut, A Tugrul Headache: The Journal of Head and Face Pain 48 (7), 1103-1107

6
ATIF

ATIFLAR

Effect of Obesity and Leptin Level on Migraineurs Z Ligong, Q Jinjin, C Chunfu, L Congcong… - … medical journal of …, 2015 - ncbi.nlm.nih.gov
Association of pediatric obesity and migraine with comparison to tension headache and samples from other countries T Eidlitz-Markus, Y Haimi-Cohen… - Journal of child …, 2015 - jcn.sagepub.com
Biochemistry of Primary Headaches P Sarchielli, S Caproni, C Costa, D Szok… - Pathophysiology of …, 2015 - Springer
Migraine and body mass index categories: a systematic review and meta-analysis of observational studies R Ornello, P Ripa, F Pistoia, D Degan, C Tiseo… - J Headache …, 2015 - biomedcentral.com
Migraine and obesity: metabolic parameters and response to a weight loss programme A Verrotti, M Carotenuto, L Altieri, P Parisi… - Pediatric …, 2015 - Wiley Online Library
Ictal adipokines are associated with pain severity and treatment response in episodic migraine NC Chai, B Gelaye, GE Tietjen, PD Dash, BA Gower… - Neurology, 2015 - AAN Enterprises

Survival of heparins, oral anticoagulants, and aspirin after the year 2010. J Fareed, DA Hoppensteadt, D Fareed, M Demir, R Wahi, M Clarke, ... Seminars in thrombosis and hemostasis 34 (1), 58-73

5
ATIF

The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: soluble CD40 ligand and high-sensitivity C-reactive protein S Guldiken, M Demir, E Arikan, B Turgut, S Azcan, M Gerenli, A Tugrul Thrombosis research 119 (1), 79-84 (January 2007)

3
ATIF

Pitfalls in the diagnosis of immune thrombocytopenic purpura in children: 4 case reports B Biner, Ö Devecioğlu, M Demir Clinical and Applied Thrombosis/Hemostasis 13 (3), 329-333

1
ATIF

Systemic antineutrophil cytoplasmic antibody vasculitis in a patient with chronic lymphocytic leukemia: quite a rare diagnosis GE Pamuk, MS Uyanık, M Demir, E Tekgündüz, B Turgut, M Soy Leukemia research 31 (8), 1149-1151

1
ATIF

The effects of nebivolol on fibrinolytic parameters in mild and moderate hypertensive patients B Tarighi, T Kurum, M Demir, SN Azcan Canadian Journal of Cardiology 23 (8), 651-655

2
ATIF

17p Deletion is associated with resistance of B-cell chronic lymphocytic leukemia cells to in vitro fludarabine-induced apoptosis B Turgut, O Vural, FS Pala, GE Pamuk, K TabakcioĞlu, M Demir, ... Leukemia & lymphoma 48 (2), 311-320

1
ATIF

Serum osteoprotegerin levels in patients with acute atherothrombotic stroke and lacunar infarct B Guldiken, S Guldiken, B Turgut, N Turgut, M Demir, Y Celik, E Arikan, ... Thrombosis research 120 (4), 511-516

2
ATIF

Altiay G, Ciftci A, Demir M, Kocak Z, Sut N, Tabakoglu E, Hatiopoglu ON, Caglar T. High plasma D-dimer level is associated with decreased survival in patients with lung cancer. Clin Oncol 2007; 19(7):494-498.

18
ATIF

ATIFLAR

CHEN, Wenxin, et al. Prognostic value of coagulation markers in patients with colorectal caner: A prospective study. Health Science Reports, 2024, 7.2: e1553.
DYBOWSKA, Małgorzata, et al. D-Dimers Variability in the Perioperative Period of Breast Cancer Surgery Helps to Predict Cancer Relapse: A Single-Centre Prospective Study. Cancer Control, 2023, 30: 10732748231204713.
SHI, Jiaran, et al. Left ventricular myocardial work index and short-term prognosis in patients with light-chain cardiac amyloidosis: a retrospective cohort study. Quantitative Imaging in Medicine and Surgery, 2023, 13.1: 133.
Predictive value of plasma D-dimer levels in patients with advanced non-small-cell lung cancer Y Wang, Z Wang - OncoTargets and therapy, 2015 - ncbi.nlm.nih.gov
D-Dimer Can Serve as a Prognostic and Predictive Biomarker for Metastatic Gastric Cancer Treated by Chemotherapy SI Go, MJ Lee, WS Lee, HJ Choi, US Lee, RB Kim… - Medicine, 2015 - ncbi.nlm.nih.gov
D-dimer Level Changes During Systemic Chemotherapy Can Predict Prognosis of High-grade Musculoskeletal Sarcoma Patients T MORII, T TAJIMA, T AOYAGI… - Anticancer research, 2015 - ar.iiarjournals.org
The prognostic value of D‐dimer in lung cancer T İnal, C Anar, G Polat, İ Ünsal… - The clinical respiratory …, 2015 - Wiley Online Library
Venous thromboembolism and lung cancer: a review C Vitale, M D'Amato, P Calabrò… - Multidisciplinary …, 2015 - mrmjournal.biomedcentral.com
Clinical significance of plasma fibrinogen and D-dimer in predicting the chemotherapy efficacy and prognosis for small cell lung cancer patients LR Zhu, J Li, P Chen, Q Jiang, XP Tang - Clinical and Translational …, 2015 - Springer
Prognostic and predictive value of plasma D-dimer in advanced non-small cell lung cancer patients undergoing first-line chemotherapy LP Ge, J Li, QL Bao, P Chen, Q Jiang… - Clinical and Translational …, 2015 - Springer
Air quality improvement during 2010 Asian games on blood coagulability in COPD patients Z Zhang, J Wang, M Guo, M Xiong, Q Zhou, D Li… - … Science and Pollution …, 2015 - Springer
Elevated serum C‐reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non‐small cell lung cancer XF Ni, P Wu, CP Wu, M Ji, J Wu, XF Gu… - Asia‐Pacific Journal of …, 2015 - Wiley Online Library
Identification of potential erythrocyte phospholipid fatty acid biomarkers of advanced lung adenocarcinoma, squamous cell lung carcinoma, and small cell lung cancer P Sánchez-Rodríguez, MC Rodríguez… - Tumor Biology, 2015 - Springer
Pretreatment plasma D-dimer, fibrinogen, and platelet levels significantly impact prognosis in patients with epithelial ovarian cancer independently of venous … YN Man, YN Wang, J Hao, X Liu, C Liu… - International Journal …, 2015 - journals.lww.com
Can D-Dimer Measurement Reduce the Frequency of Radiological Assessment in Patients Receiving Palliative Imatinib for Gastrointestinal Stromal Tumor (GIST)? M Afshar, P Hamilton, J Seligmann, S Lord… - Cancer …, 2015 - Taylor & Francis
Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: A systematic review and meta-analysis C Perisanidis, A Psyrri, EE Cohen, J Engelmann… - Cancer treatment …, 2015 - Elsevier
The preoperative plasma D-dimer level is an independent prognostic factor in patients with completely resected non-small cell lung cancer K Fukumoto, T Taniguchi, N Usami, K Kawaguchi… - Surgery today, 2015 - Springer
High pretreatment plasma D-dimer levels are associated with poor prognosis in patients with ovarian cancer independently of venous thromboembolism and … M Sakurai, T Satoh, K Matsumoto… - International Journal …, 2015 - ncbi.nlm.nih.gov

Tarighi, Bahman; Kurum, Turhan; Demir, Muzaffer; et al. The effects of nebivolol on fibrinolytic parameters in mild and moderate hypertensive patients, CANADIAN JOURNAL OF CARDIOLOGY Volume: 23 Issue: 8 Pages: 651-655 Published: JUN 2007

Systemic antineutrophil cytoplasmic antibody vasculitis in a patient with chronic lymphocytic leukemia - Quite a rare diagnosis Pamuk, Gulsum Emel; Uyanik, Mehmet Sevki; Demir, Muzaffer; et al. LEUKEMIA RESEARCH Volume: 31 Issue: 8 Pages: 1149-1151 Published: AUG 2007

Factor V Leiden mutation, deficiency of antithrombin III and elevation of factor VIII in a child with ischemic stroke: A case report R Duran, B Biner, M Demir, C Çeltik, S Karasalihoğlu, B Acunaş Brain and Development 28 (9), 604-606

2
ATIF

Dorsal sural nerve conduction study in vitamin B12 deficiency with megaloblastic anemia B Turgut, N Turgut, S Akpinar, K Balci, GE Pamuk, E Tekgündüz, M Demir Journal of the Peripheral Nervous System 11 (3), 247-252

2
ATIF

Increased adiponectin level in non-Hodgkin lymphoma and its relationship with interleukin-10. Correlation with clinical features and outcome. GE Pamuk, B Turgut, M Demir, O Vural Journal of experimental & clinical cancer research: CR 25 (4), 537-541

2
ATIF

Increased circulating platelet–leucocyte complexes in patients with primary Raynaud's phenomenon and Raynaud's phenomenon secondary to systemic sclerosis: a comparative study GE Pamuk, B Turgut, ÖN Pamuk, Ö Vural, M Demir, N Çakr Blood coagulation & fibrinolysis 18 (4), 297-302

3
ATIF

Hypercoagulopathy in stroke patients with nonvalvular atrial fibrillation: hematologic and cardiologic investigations N Turgut, O Akdemir, B Turgut, M Demir, G Ekuklu, Ö Vural, G Özbay, ... Clinical and applied thrombosis/hemostasis 12 (1), 15-20

2
ATIF

Increased circulating platelet–neutrophil, platelet–monocyte complexes, and platelet activation in patients with ulcerative colitis: a comparative study GE Pamuk, Ö Vural, B Turgut, M Demir, H Ümit, A Tezel American journal of hematology 81 (10), 753-759

6
ATIF

ATIFLAR

WARPECHOWSKI, Marcin, et al. Neutrophil-to-Platelet Ratio in Patients with Ulcerative Colitis Treated with Infliximab or Vedolizumab: A Retrospective, Single-Center Study in Poland. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 2023, 29: e938827-1.
DORKEN-GALLASTEGI, Ander, et al. Circulating cellular clusters are associated with thrombotic complications and clinical outcomes in COVID-19. Iscience, 2023, 26.7: 107202.
Effect of Cellulose Acetate Beads on the Release of Transforming Growth Factor‐β S Nishise, Y Abe, E Nomura, T Sato… - Therapeutic …, 2015 - Wiley Online Library
Platelet-neutrophil complex formation—a detailed in vitro analysis of murine and human blood samples M Mauler, J Seyfert, D Haenel… - Journal of leukocyte …, 2015 - Soc Leukocyte Biology
Characterization of serum cytokine profile in predominantly colonic inflammatory bowel disease to delineate ulcerative and Crohn's colitides OY Korolkova, JN Myers, ST Pellom… - Clinical medicine …, 2015 - ncbi.nlm.nih.gov
Platelets in inflammation: regulation of leukocyte activities and vascular repair A Gros, V Ollivier, B Ho-Tin-Noé - Front Immunol, 2015 - lvts.fr

Leptin and resistin levels in serum of patients with hematologic malignancies: correlation with clinical characteristics GE Pamuk, M Demir, F Harmandar, Y Yesil, B Turgut, O Vural Exp Oncol 28 (3), 241-244

5
ATIF

Overexpression of cyclooxygenase‐2 in multiple myeloma: Association with reduced survival M Cetin, S Buyukberber, M Demir, I Sari, I Sari, K Deniz, B Eser, F Altuntas, ... American journal of hematology 80 (3), 169-173

4
ATIF

Global fibrinolytic capacity in patients with subclinical hypothyroidism S GULDIKEN, M DEMIR, B TURGUT, BU ALTUN, E ARIKAN, M KARA Endocrine journal 52 (3), 363-367

3
ATIF

Factor V Leiden mutation and other thrombophilia markers in childhood ischemic stroke R Duran, B Biner, M Demir, C Çeltik, S Karasalihoğlu Clinical and applied thrombosis/hemostasis 11 (1), 83-88

8
ATIF

ATIFLAR

MAHER, Kristin, et al. Thrombophilia screening in the routine clinical care of children with arterial ischemic stroke. Pediatric Blood & Cancer, 2023, e30381.
GENETICALLY DETERMINED THROMBOPHILIA IN CHILDHOOD LV Zhdanova - … ИНФЕКЦИИ В БУРЯТИИ В 2012–2014 гг., 2015 - bsu.ru
Revisão sistemática: trombofilias hereditárias associadas aos acidentes vasculares cerebrais pediátricos ea paralisia cerebral VM Torres, VA Saddi - Jornal de Pediatria, 2015 - redalyc.org
Prothrombotic risk factors and antithrombotic therapy in children with ischemic stroke AA Eltayeb, GA Askar, NHA Faddan… - Therapeutic advances …, 2015 - tan.sagepub.com
Factoring in Factor VIII with acute ischemic stroke JE Siegler, A Samai, KC Albright… - Clinical and Applied …, 2015 - cat.sagepub.com
The role of biochemical risk factors in the etiology of AIS in children and adults I Kopyta, M Zimny, B Sarecka-Hujar - International Journal of …, 2015 - Taylor & Francis
Significant risk factors in the etiology of arterial ischemic stroke in children I Kopyta, M Zimny - CNS, 2015 - oruen.com
Systematic review: hereditary thrombophilia associated to pediatric strokes and cerebral palsy VM Torres, VA Saddi - Jornal de Pediatria (Versão em Português), 2015 - Elsevier

Inflammatory pseudotumor of the spleen with EBV positivity: report of a case F Oz Puyan, S Bilgi, E Unlu, O Yalcin, S Altaner, M Demir, B Cakir European journal of haematology 72 (4), 285-291

5
ATIF

Pulmonary alveolar proteinosis in a patient with acute lymphoid leukemia regression after G-CSF therapy GE Pamuk, B Turgut, Ö Vural, M Demir, O Hatipoğlu, E ÜnlÜ, Ş Altaner, ... Leukemia & lymphoma 44 (5), 871-874

2
ATIF

Candida arthritis in a patient with chronic myelogenous leukemia (CML) in blastic transformation, unresponsive to fluconazole, but treated effectively with liposomal amphotericin B B Turgut, Ö Vural, M Demir, M Kaldir Annals of hematology 81 (9), 529-531

1
ATIF

Nucleated red blood cell counts and erythropoietin levels in high‐risk neonates Ü Vatansever, B Acuna, M Demİr, S KarasalİhoĞlu, G Ekuklu, S Ener, ... Pediatrics international 44 (6), 590-595

1
ATIF

Demir M, Iqbal O, Dietrich CP, Hoppensteadt DA, Ahmad S, Daud AN, Fareed J. Anticoagulant and antiprotease effects of a novel heparinlike compound from shrimp (Penaeus brasiliensis) and its neutralization by heparinase I. Clin Appl Thrombosis/Hemostasis 2001; 7(1):44-52.

1
ATIF

Primary angiosarcoma of the spleen: in vivo and in vitro MRI findings HM Karakas, M Demir, F Ozyilmaz, B Cakir Clinical imaging 25 (3), 192-196

2
ATIF

The prevalence of hereditary thrombophilia in the Trakya region of Turkey M Demir, O Vural, H Sunar, A Altun, F Yorulmaz, G Ozbay Yonsei medical journal 41 (4), 436-440

1
ATIF

Clinical characteristics of haematological malignancy patients diagnosed with leukaemia cutis: Experience of a single centre.

International Articles

Bulduk T, Demir AM, Andıç N, Sayınalp N, Aylı M. History of the Hematology Proficiency Exam and the Turkish Experience. Sürekli Tıp Eğitimi Dergisi 2023;32(4):281-291 (December 2023)

Serez Kaya B, Yılmam İ, Çakır Edis E, Karabulut D, Elmaslar Mert T, Eryıldız C, Demir M. Case of Prolonged Viral Shedding: Chronic, Intermittan COVID-19? Turkish Thoracic Journal 2023;23(1):85-88. (July 2023)

Alp Kırkızlar T, Demir AM. Evaluation of leukapheresis and leukapheresis with additional cytoreduction in acute leukemia with hyperleukocytosis. Turk J Internal Med 2023;5(3):191-198. (July 2023)

ŞM Özgenel, AM Demir. Comparison of risk factors for warfarin associated bleeding. Ankara Medical Journal 2023;23 (1):120-131 (January 2023)

.G. E. ÜMIT, M. BAYSAL, V. BAS, H. GOZE, V. ASOGLU, O. H. KIRKIZLAR, M. A. DEMIR, Value of Extracellular High Mobility Group Box 1 (HMGB1) in the Clinical Context of Immune Thrombocytopenia, Journal of Clinical and Experimental Investigations, vol. 10, no. 2, pp. 11-16, 1, 2019.

.G. E. ÜMIT, C. H. ÜMIT, H. GÖZE, M. BAYSAL, M. A. DEMIR, Reactivation of Hepatitis B Virus Infection 66 months after Rituximab Therapy For Chronic Lymphocytic Leukemia, Emphasis on Interplay between Infection, Drugs and Disease Biology, Eastern Journal Of Medicine, vol. 24, no. 3, pp. 371-374, 1, 2019.

.M. BAYSAL, G. E. ÜMIT, C. A. ÖZDÖVER, H. SUTCU, G. I. Ç. UZUN, O. H. KIRKIZLAR, C. N. SAYIN, M. A. DEMIR, Acute Promyelocytic Leukemia Diagnosed at the End of First Trimester with a Successful Outcome, Eurasian Journal of Medicine and Oncology, vol. 2, no. 4, pp. 258-260, 10, 2018.

.Y. A. AVCi, M. A. DEMIR, U. UTKU, Ö. VURAL, G. EKUKLU, The relationship between serum interleukin-6 levels with lesion size and early functional worsening in acute ischemic stroke, Acta Medica Alanya, vol. 2, no. 2, pp. 102-110, 7, 2018.

.G. E. ÜMIT, M. BAYSAL, O. H. KIRKIZLAR, M. A. DEMIR, Splanchnic Venous Thrombosis, with Spotlight on Occult Malignancies, Anticoagulation, and Bleeding, European Journal of Therapeutics, vol. 24, pp. 112-114, 7, 2018.

.G. E. ÜMIT, M. BAYSAL, M. A. DEMIR, Multiple Myeloma and Thromboembolism in the Perspective of Age and Performance, Journal of Hematology Thromboembolic Diseases, vol. 5, no. 02, pp. 267-267, 1, 2017.

International Conference Proceedings

TA Kirkizlar, O Kirkizlar, AM Demir, EG Umit. P977. The venous thromboembolism risk assessment models in multipl myeloma. HemaSphere 2023;7(S3):e2045172 (August 2023)

PL Zinzani, J Mayer, O Benjamini, A Berkovits, I Glimelius, D Stevens, A Chaudhry, AM Demir, RG Sanz, WS Kim, F Li, J Halka, A Marin‐Niebla, M Ozcan, E Paszkiewicz‐Kozik, A Santoro, Y Ren, U Ogbu, P Marinello, W Jurczak. A phase 2 study of zilovertamab vedotin as monotherapy or in combination in patients (pts) with aggressive and indolent B‐cell malignancies: waveLINE‐006. Hematological Oncology 2023;41:564-565 (June 2023)

Demirci U, Ümit EG, Özdemir H, Tuna F, Kabayel D, Demir AM. Effect of excercise training on physical activity in adult severe hemophilia A patients. Hemophilia 2023; S1:66 PO082 (February 2023)

Demir, AM, Demirci U, Ümit EG. Longterm outcomes of pharmacokinetic based individualized prophylaxis in patients with hemophilia A without inhibitors. Hemophilia 2023; S1: 65-66 PO081 (February 2023)

PL Zinzani, J Mayer, O Benjamini, A Berkovits, I Glimelius, D Stevens, A Chaudhry, AM Demir, RG Sanz, WS Kim, F Li, J Halka, A Marin‐Niebla, M Ozcan, E Paszkiewicz‐Kozik, A Santoro, Y Ren, U Ogbu, P Marinello, W Jurczak. waveLINE-006: A phase 2 study of the safety and efficacy of zilovertamab vedotin as monotherapy or in combination in patients (pts) with aggressive and indolent B-cell malignancies. J Clin Oncol 2023;41(16):STPS57595

.M. BEKSAÇ, G. S. CENGIZ, S. PAYDAS, T. A. TUGLULAR, Ö. ARSLAN, H. GÖKER, L. KAYNAR, F. ALTUNTAS, F. ATALAY, H. TEKE, Z. A. BOLAMAN, M. PEHLIVAN, M. SÖNMEZ, M. A. DEMIR, P. TOPCUOGLU, M. YILMAZ, H. S. KABUKÇU, M. ALBAYRAK, N. Y. ÖZGÜR, A. SALIHOGLU, M. ÇAKAR, G. GURMAN, Elotuzumab Plus Pomalidomide or Lenalidomide is Able to Achieve Durable = Vgpr Responses Among Immunomodulatory/Proteasome Inhibitor Refractory Myeloma Patients: A Report on Multicenter Experience From Turkey, 17th International Myeloma Workshop, vol. 19, no. 10, pp. 242-243, Boston-AMERIKA BIRLESIK DEVLETLERI.

.H. GOZE, G. E. ÜMIT, M. A. DEMIR, Role of Monocyte Chemoattractant Proteins in the Pathogenesis of Immune Thrombocytopenia, 25TH BIENNIAL INTERNATIONAL CONGRESS ON THROMBOSIS, vol. 2, no. 2, pp. 734-735.

.G. E. ÜMIT, H. GÖZE, M. BAYSAL, M. A. DEMIR, Plasmic Score for the Initial Evaluationof Patients with Microangiopathic HemolyticAnemia and Thrombocytopenia, International Society of Haemostasis and Thrombosis Annual Meeting 2018, vol. 1, no. 1, pp. 78-79, Dublin-IRLANDA.

.V. ASOGLU, G. E. ÜMIT, M. A. DEMIR, Tumor Necrosis Factor ReceptorAssociated Factor 6 (TRAF6) in the Pathogenesisof Immune Thrombocytopenia, International Society of Haemostasis and Thrombosis ISTH Annual Meeting 2018, Dublin-IRLANDA.

.G. E. ÜMIT, M. BAYSAL, H. GÖZE, V. ASOGLU, C. A. ÖZDÖVER, O. H. KIRKIZLAR, M. A. DEMIR, The Impact Of High Mobility Group Box 1 in the Pathogenesis of Immune Thrombocytopenia, European Hematology Association 23rd Annual Meeting 2018, vol. 1, no. 1, pp. 345-346, Stockholm-ISVEÇ.

.S. ULUSAL, G. E. ÜMIT, H. GÜRKAN, H. TOZKIR, M. BAYSAL, E. GÖNCÜ, D. EKER, M. A. DEMIR, Screening for CALR gene mutations in Jak-2 V617F mutation negative patients with myeloproliferative neoplasms, EUROPEAN HUMAN GENETICS CONFERENCE.

.H. G. ÖZSAN, G. Ö. SEVINDIK, S. SEVIL, K. S. HACIOGLU, Y. S. KAYA, A. GEDUK, U. A. URAL, F. T. TUGLULAR, V. ÖZKOCAMAN, M. A. DEMIR, Y. AYDIN, A. G. ÇAGLAYAN, I. AYDOGDU, M. PEHLIVAN, M. I. YARADILMIS, V. KARAKUS, M. YILMAZ, M. BEKSAÇ, Real-World Data in Relapsed Refractory Myeloma Patients Treated with Pomalidomide, a Multicenter Turkish Experience, 59th ASH Annual Meeting, vol. 130, no. SPP1, pp. 5430-5430, WASHINGTON-AMERIKA BIRLESIK DEVLETLERI.

.H. G. ÖZSAN, G. Ö. SEVINDIK, S. SEVIL, S. HACIOGLU, S. KAYA, A. GEDUK, U. A. URAL, T. A. TUGLULAR, V. ÖZKOCAMAN, M. A. DEMIR, Y. AYDIN, G. Ç. AKGÜN, I. AYDOGDU, M. PEHLIVAN, M. I. YARADILMIS, V. KARAKUS, M. YILMAZ, M. BEKSAÇ, REAL WORLD DATA IN RELAPSED REFRACTORY MYELOMA PATIENTS TREATED WITH POMALIDOMIDE, A MULTICENTER TURKISH EXPERIENCE, American Society of Hematology Congress, vol. 130, pp. 5430-5430.

.H. G. ÖZSAN, G. Ö. SEVINDIK, S. SADRI, S. HACIOGLU, S. KAYA, A. GEDUK, U. A. URAL, T. A. TUGLULAR, V. ÖZKOCAMAN, M. A. DEMIR, Y. AYDIN, G. Ç. AKGÜN, I. AYDOGDU, M. PEHLIVAN, M. I. YARADILMIS, V. KARAKUS, M. YILMAZ, M. BEKSAÇ, REAL-WORLD DATA IN RELAPSED REFRACTORY MYELOMA PATIENTS TREATED WITH POMALIDOMIDE , A MULTI CENTER TURKISH EZXPERIENCE, AMERICAN HEMATOLOGY MEETING, vol. 130, pp. 5430-5430, -AMERIKA BIRLESIK DEVLETLERI.

.G. E. ÜMIT, M. BAYSAL, O. H. KIRKIZLAR, M. A. DEMIR, Economic analysis of posaconazole prophylaxis in patients with acute myeloid leukemia undergoing remission induction chemotherapy from a hospital management perspective. Poster No: 2126, 59th American Society of Hematology Annual Meeting and Exposition, ATLANTA-AMERIKA BIRLESIK DEVLETLERI.

.M. MADEN, E. ÜMIT, E. S, M. A. DEMIR, EFFICIENCY OF DIRECT ORAL ANTICOAGULANTS ON ANTIPHOSPHOLIPID ANTIBODY SYNDROME A CASE REPORT, 24th Biennial International Congress on Thrombosis / EMLTD Congress, vol. 141, no. 1, pp. 340-340, Oxford-INGILTERE.

.E. ÜMIT, M. A. DEMIR, IMPACT OF AGE ON GENERAL FEATURES OF PATIENTS WITH IMMUNE THROMBOCYTOPENIA IN TRAKYA REGION TURKEY, 24th Biennial International Congress on Thrombosis / EMLTD Congress, vol. 141, no. 1, pp. 80-81, OXFORD-INGILTERE.

.E. ÜMIT, M. A. DEMIR, MULTIPLE MYELOMA AND THROMBOSIS, 24th Biennial International Congress on Thrombosis / EMLTD Congress, vol. 141, no. 1, pp. 51-51, OXFORD-INGILTERE.

.D. ÇEKDEMIR, F. ÖZDEMIRKiRAN, G. S, A. ESER, V. ÖZKOCAMAN, M. A. DEMIR, USE OF ELTROMBOPAG IN IMMUNE THROMBOCYTOPENIA IN TURKEY, 24th Biennial International Congress on Thrombosis / EMLTD Congress, vol. 141, no. 16-18, pp. 16-18, OXFORD-INGILTERE.

Ozgenel M, Umit E, Turan N, Demir M. Comparison of risk factors for warfarin associated bleeding. XXV. Congress of the International Society on Thrombosis and Haemostasis and 61st Annual SSC Meeting JUne 20-25 2015 Toronto Canada. PO-617-TUE (June 2015)

Clinical feautes of myelodysplastic syndrome patients in one center in Northwestern of Turkey. Pamuk GE, Uyanık MS, Maden M, Oz puyan F, Demir M. The 13 th International Symposium on Myelodysplastic syndromes April 29, May 2 2015, Washington DC USA (April 2015)

.O. MERIÇ, Ü. ELIF, N. F. TURAN, M. A. DEMIR, Comparison of risk factors for warfarin associated bleeding XXV Congress of The ISTH and 61 Annual SSC Meeting June 20 25 2015 Toronto Canada, XXV. Congress of The ISTH and 61. Annual SSC Meeting, Toronto-KANADA.

.M. A. DEMIR, Management of bleeding complications of anticoagulants, 18th International Meeting Danubian League against Thrombosis and Haemorragic Disorders.

.G. E. ÜMIT, B. D. ESEN, M. BAYSAL, M. A. DEMIR, Depression as the presenting symptom of central nervous system lymphomas in Northwestern Turkey. Haematologica 2014 99(1): PB2134:581,, 22th Congress of the European Hematology Assosiation, vol. 99, no. 1, pp. 581-.

Akpınar S, Pamuk GE, Tozkır H, Gürkan H, Duymaz J, Demir M, Pamuk ON. The significance of KIR gene polymorphisms in chronic lymphocytic leukemia. Haematologica 2014;99(1): PB1494:581, 19th Congress of the European Hematology, June 12-15, 2014, Milan, Italy

Demir M, Ümit EG, Uyanık Ş, Maden M, Tokuç B, Puyan F, Pamuk GE.Mortality and related factors in elderly patients with acute myleoid leukemia. Haematologica 2014;99(1): P1474:573-574 , 19th Congress of the European Hematology, June 12-15, 2014, Milan, Italy

Pamuk, GE, Sahip B, Uyanik, MS, Demir, M, Pamuk, ON. Is higher IL-21 level predictive of relapses in immun thrombocytopenia and is it associated with activation of the comlement system? Haematologica 2014;99(1): P1218:468 , 19th Congress of the European Hematology, June 12-15, 2014, Milan, Italy

Pamuk, GE, Uyanik, MS, Karaca, T, Selim, D, Demir, M, Pamuk, ON. Spleen Tyrosine Kinase Inhibitor, Fostamatinib, on an Immune Thrombocytopenia Mouse Model. 56th Annual Meeting of the American Society of Hematology, Dec 06-09, 2014, San Francisco, Blood 2014; 124 (21).

Demir M, Tabakçıoğlu K. Hemoglobin Edirne: A new δ – chain variant:[δ 53 (D4)ASP> HIS, HBD C. 160G>C]. 8. Balkan Hematology Day, 25 Octobr 2013, Antalya. Abstract:0644 [B-09] (October 2013)

Demir M, Halhalli S, Tezel A, Ustundag A, Can G and Umit E. Assessment of thrombin formation in patients with ulcerative colitis without a history of thrombotic events. XXIV Congress of the International Society on thrombosis and Haemostasis, June 29-July 4 2013, Amsterdam. J Thromb Hemost 2013;11 (Suppl. 2):PA 1.11-3 (July 2013)

G. Pamuk, M. Uyanık, M. Akker, M. Tascı, F. Puyan, M. Demir, O. Harmandar. Epidemiological data and clinical features of 205 non-hodgkin lympmoa patients at a single center in Turkey. Haematologica 2013; 98(s1):B1643 (June 2013)

E. Umit, B. Serim, G. Altun, F. Puyan, G. Pamuk, M. Demir. Comparision of bone marrow involvement by FDG PET/CT and histopathology in patients with lymphoma. Haematologica 2013; 98(s1):B1424 (June 2013)

The cost-of-disease of thromboembolic and hemorrhagic complications associated with atrial fibrillation and its treatment in Turkey: an expert panel approach for estimation of costs C Deger, O Ozdemir, K Bozkurt, M Demir, B Ince, H Kultursay, G Ongen, ... Value in Health 16 (3), A281

Marmaralı B, Özdemir O, Bozkurt K, Demir M, İnce B, Kültürsay H, Öngen G, Öngen Z, Deger C, Özel MO.The cost of effectiveness of rivaroxaban compared to enoxaparin plus adjusted döşe warfarin for the tretment of deep venous thrombosis in Turkey. Value in Health 2013;16(3):A288.

Marmaralı B, Özdemir O, Bozkurt K, Demir M, İnce B, Kültürsay H, Öngen G, Öngen Z, Deger C, Özel MO.The cost of effectiveness of rivaroxaban for the prevention of stroke in patients with atrial fibrillton in Turkey. Value in Health 2013;16(3):A285.

Deger C, Özdemir O, Bozkurt K, Demir M, İnce B, Kültürsay H, Öngen G, Öngen Z, Marmaralı B, Özel MO.The cost of disease of thromboembolic and hemorrhagic complications associated with atrial fibrillation and its treatment in Turkey: An expert panel approach for estimation of costs. Value in Health 2013;16(3):A281.

Deger C, Özdemir O, Bozkurt K, Demir M, İnce B, Kültürsay H, Öngen G, Öngen Z, Marmaralı B, Özel MO. The cost of disease of deep venous thrombosis and its short and long term clinicl consequences in Turkey: An expert panel approach for estimation of costs. Value in Health 2013;16(3):A282.

1
ATIF

Serim BD, Ümit EG, Üstün F, Aksoy S, Demir M, Altun GD.The role of indices obtained from positron emission tomography for predicting prognosis in patients with NonHodgkin’s Lymphomas Euro J Nuclear Med Molecular Imaging 2013; 40(2): S475.; Annual Congress of the European Association of Nuclear Medicine (EANM), October 19-23 Lyon France.

Pamuk GE, Köylü A, Uyanık MŞ, Demir M, Pamuk ON. The epidemiology of immune thrombocytopenia and clinical features of patients at single center in Northwestern Turkey. Blood 2013; 122(21): A4750; 55th Annual Meeting of the American Society of Hematology New Orleans, LA, Dec 03-03, 2013

Serim BD, Ümit E, Üstün F, Aksoy S, Demir M, Altun GD. The role of indices obtained from positron emission tomography for predicting prognosis in patients with non-Hodgkin’s lymphomas. European j Nuclear Med Molecular İmaging 2013: 40(2): S475

Demir M, Ümit E, Kırkızlar O, Akpınar S, Uyanık MŞ, Pamuk GE. Lenalidomide and Related Factors in Myeloma Patients, Single Center Experience. 14. International Myloma Workshop April 3rd-7th 2013, Kyoto, Japan, Clin Lymphoma, Myeloma Leukemia 2013: 13 (supp 1): P397

Umit EG, Uyanık M, Kuloğlu F, Pamuk GE, Demir M. Neutropenic enterocolitis and vancomycin resistant enterococcus as predisposng factor. 18. Congress of the European Hematology Association June 13-16 2013 Stockholm Sweden. Haematologica 2013; (1): P432

Role of PAI-1 and TAFI in the mediation of fibrinolytic deficit in cancer patients MR Florian-Kujawski, D Hoppensteadt, O Iqbal, M Demir, M Tobu, ... ASCO Annual Meeting Proceedings 22 (14_suppl), 9727

1
ATIF

.YILMAZ ERDEM,TUYGUN ABDULLAH KEMAL,BINGÖL ÖZAKPINAR ÖZLEM,DEMIR AHMET MUZAFFER,URAS FIKRIYE, Plasma Matrix Gla Protein and Gas6 levels in patients with coronary artery disease, Clinical Chemistry (AACC Annual Meeting 2011), vol. 57, no. 10.

International Conferences and Symposiums

18.th International Meeting of the Danubian League against Thrombosis and Haemorragic Disorders, Sarajevo Bosnia and Herzegovina May 14-16 2015 Konuşmacı Management of bleeding due to anticoagulants

Oturum başkanlığı, Chabannon C, Demir M. Progress in the collection and processing of minimally manipulated hematopoiteic cell products. EBMT 2015, 41st Annual Meeting of the European Society for Blood and Marrow Transplantation, 22nd-25th March 2015, Istanbul-Turkey

Oturum Başkanlığı, Presidential Farewell Symposium: New Challenges in thrombosis and cardiovascular disease. 23rd Biannual International Congress on Thrombosis Valencia, Spain 14-17 May 2014

Kongre Sekreteri, 4. International Congress on Leukemia Lymphoma Myeloma, 22-25 Mayıs 2013, WOW Kongre Merkezi, İstanbul (May 2013)

International Books and Book Chapters

.M. A. DEMIR, K. M. ADALi, O. H. KIRKIZLAR, M. AKTOZ, T. AKTOZ, S. AYTÜRK, Ö. BENIAN, B. ÇAMUR, M. ÇELIK, Taylor Ayirici Tani, Uluslararasi, Basim Türü: Basili, TÜRKIYE-ANKARA, ISBN978-975-277-684-5, GÜNES TIP KITAPEVLERI, 20181. Basim.

.M. A. DEMIR, A. M. YILMAZTEPE, G. TAYLAN, M. AKTOZ, Taylor Ayirici Tani, Uluslararasi, Bölüm: Kardiyovasküler Problemler, Basim Türü: Basili, TÜRKIYE-, Günes Tip Kitapevleri, 20171. Basim.

National Articles

Alp Kırkızlar T, Demir AM, Evaluation Of Hypomethylating Agent Venetoclax Combination In Patients With Acute Myeloid Leukaemia Ineligible For Intensive Treatment, Osmangazi Journal of Medicine, 2024;46(2):275- 283 Doi: 10.20515/otd.1436206 (March 2024)

Comparison of Hemophagocytic Lymphohistiocytosis Diagnostic Criteria in Malignancy-Associated Hemophagocytic Lymphohistiocytosis Patients. Kırkızlar HO, Alp Kırkızlar T, Demirci U, Karaman Gulsaran S, Bas V, Umit EG, Demir AM. Turkish J Intern Med 2022;4(4):180-189. https://doi.org/10.46310/tjim.1121064

.DEMIRCI UFUK, KARAMAN GÜLSARAN SEDANUR, BAS VOLKAN, ÜMIT ELIF GÜLSÜM, KIRKIZLAR HAKKI ONUR, DEMIR AHMET MUZAFFER, Management of Patients with Factor VII Deficiency in Surgery: Single Center Experience, Erciyes Medical Journal, 2021. (January 2021)

.DEMIR AHMET MUZAFFER, INAN MUSTAFA, ÖZ PUYAN FULYA, TOPÇU TARLADAÇALISIR YETER, ERDOGAN BÜLENT, GAYEF ALBENA, ÇALOGLU HASAN MURAT, TEZEL HÜSEYIN AHMET, Trakya University Faculty of Medicine Undergraduate Medical Education Practices in COVID-19 Pandemic Process, Tip Egitimi Dünyasi, vol. 20, pp. 72-77, 2021.

.DEMIRCI UFUK, KARAMAN GÜLSARAN SEDANUR, BAS VOLKAN, ÜMIT ELIF GÜLSÜM, KIRKIZLAR HAKKI ONUR, DEMIR AHMET MUZAFFER, Ruksolitinib Tedavisinin Aniden Kesilmesi Sonrasinda Post-ET Myelofibrozis Bulgularinda Alevlenme: Akilda Kalmasi Gereken Bir Klinik Tablo, LLM Dergi, vol. 5, no. 2, pp. 52-55, 2021.

.DEMIR AHMET MUZAFFER, INAN MUSTAFA, ÖZ PUYAN FULYA, TOPÇU TARLADAÇALISIR YETER, ERDOGAN BÜLENT, GAYEF ALBENA, ÇALOGLU HASAN MURAT, TEZEL HÜSEYIN AHMET, COVID-19 Pandemisi Sürecinde Trakya Üniversitesi Tip Fakültesi Mezuniyet Öncesi Tip Egitimi Uygulamalari , Tip Egitimi Dünyasi, vol. 60, no. 1, pp. 72-77, 2021.

.S. D. ARICI, M. A. DEMIR, E. GÜRPINAR, Medical Faculty - National Core Curriculum 2020, Tip Egitimi Dünyasi, vol. 57, no. 1, pp. 1-146, 6, 2020.

.I. E. ATLI, H. GÜRKAN, H. TOZKIR, G. E. ÜMIT, S. DEMIR, S. YALÇINTEPE, E. ATLI, M. A. DEMIR, Multiple Myelom (MM) Tanisi Alan Olgularda Kromozomal Degisimler, Gaziosmanpasa Üniversitesi Tip Fakültesi Dergisi, no. 1, pp. 8-19, 10, 2018.

.A. A. YILMAZ, M. A. DEMIR, U. UTKU, Ö. A. VURAL, G. EKUKLU, Akut iskemik inmede serum interlökin-6 du¨zeylerinin lezyon bu¨yu¨klu¨gu¨ ve erken dönem fonksiyonel kötu¨lesme ile iliskisi, Acta Medica Alanya, vol. 2, no. 2, pp. 102-110, 7, 2018.

.N. P. BÜYÜKKOYUNCU, N. TURGUT, G. ALTIAY, M. A. DEMIR, B. TURGUT, H. ERBAS, N. SÜT, Kronik obstrüktif akciger hastaligi olan hastalarda kognitif fonksiyonlarin degerlendirilmesi, Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy, vol. 14, no. 1, pp. 109-114, 3, 2018.

.Ç. KUZUGÜDEN, S. GÜLDIKEN, S. ÜSTÜNDAG, M. ÇELIK, M. A. DEMIR, S. S. AYTÜRK, Osteoprotegerin and Receptor Activator of Nuclear Factor Kappa B Ligand In Type 2 Diabetic Nephropathy, Acta Medica Anatolia, vol. 5, no. 1, pp. 1-8, 2017.

Kırkızlar OH, Demir AM. Castelman Hastalığı. Hematolog 2015;5(2):452-458.
Kırkızlar OH, Demir AM. Lenfomatoid Granülomatozis. Hematolog 2015;5(2):459-463.

Demir AM, Uğur-Ümit E. Trombositopeniler ve trombosit işlev bozukluklarına yaklaşım Türkiye Klinikleri Hematoloji Özel Sayısı 2014;7(2):7-13

Türkiye Klinikleri Hematoloji Özel Sayısı: Trombositopeniler ve Trombosit İşlev Bozuklukları 2014;7(2):1-88

Demir AM. Non-valvüler atrial fibrilasyonda antikoagülasyon. Hematolog 2014;4(39):542-461.
Demir AM. Cerrahide venöz tromboembolizm profilaksisi. Hematolog 2014;4(39):460-479.

Demir AM, Uğur-Ümit E. Esansiyel trombositemi. Türkiye Klinikleri Hematoloji Özel Sayısı 2013;6(2):19-25

Demir M, Ümit E. Esansiyel trombositemi. Turkiye Klinikleri J Hem Onc-Special Topics 2013;6(2):19-25

.E. I. A. TEGÜNDÜZ, E. ÖZTÜRK, E. G. PAMUK, B. TURGUT, F. P. ÖZ, M. A. DEMIR, Testicular Plasmacytoma: Case Report., Turkiye Klinikleri Tip Bilimleri Dergisi , vol. 30, no. 1, pp. 430-434, 2010.

Antithrombotic and Anticoagulant Usage Policies. Trakya Univ Tip Fak Derg 2010; 27(1):69-73. Demir M, Tekgündüz E.

1
ATIF

Thrombolytic treatment in a case of pulmonary thromboembolism subsequent to IVIG therapy for immune thrombocytopenic purpura ÇE Edis, Ö Yıldız, M Demir, T Çağlar İzmir Göğüs Hastanesi Dergisi 24, 129-133

1
ATIF

National Conference Proceedings

.G. E. ÜMIT, M. BAYSAL, O. H. KIRKIZLAR, M. A. DEMIR, Philadelphia Negatif Kronik Myeloproliferatif Neoplazmlarda MPN-10 Semptom Degerlendirme Ölçegi, Genetik Yük ve Tromboz ile Iliskisi, 44.Ulusal Hematoloji Kongresi, Antalya-TÜRKIYE.

.I. E. ATLI, G. E. ÜMIT, Ç. AKURUT, M. BAYSAL, H. GÜRKAN, M. A. DEMIR, Interpretation of Cytogenetic/FISH Results in Multiple Myeloma, 3. Hematolojik Genetik Sempozyumu, vol. 1, no. 1, pp. 67-68, Izmir-TÜRKIYE.

.G. E. ÜMIT, M. BAYSAL, C. A. ÖZDÖVER, O. H. KIRKIZLAR, M. A. DEMIR, Ileri Yas Akut Myeloid Lösemi Hastalarinda Antifungal Profilaksisinin Yeri ve Etkinligi, 44.Ulusal Hematoloji Kongresi, Antalya-TÜRKIYE.

.N. E. TIFTIK, M. O. AKAY, D. ALBAYRAK, F. ERDEN, H. T. ÜSKÜDAR, M. SÖNMEZ, G. ÖZGÜR, Y. I. AVCI, G. ÖZET, I. KARADOGAN, H. OKUTAN, N. ERTUGRUL, M. SENCAN, G. E. ALANOGLU, S. ERTOP, G. ÇETIN, F. DEMIRKAN, Y. AYDINOK, M. A. DEMIR, AKUT TRANSFÜZYON REAKSIYONLARININ ANALIZI(TRANSFÜZYON HEMSIRESI ˜ HEMOVIJILANS HEMSIRESIMODEL PROJESI), 43NCÜ ULUSAL HEMATOLOJI KONGRESI, -TÜRKIYE.

.A. TOPAL, M. BAYSAL, G. E. ÜMIT, O. H. KIRKIZLAR, M. A. DEMIR, Gastrointestinal Kanamanin Nadir bir Nedeni: Diffüz Büyük B Hücreli Non Hodgkin Lenfoma, Ulusal Hematoloji Kongresi 2017, Antalya-TÜRKIYE.

.S. BOZKAYA, M. BAYSAL, G. E. ÜMIT, O. H. KIRKIZLAR, M. A. DEMIR, Primer Özofageal Diffüz Büyük Be Hücreli Lenfoma: Olgu Sunumu, Ulusal Hematoloji Kongresi 2017, Antalya-TÜRKIYE.

.G. E. ÜMIT, M. BAYSAL, Y. DÜRMÜS, O. H. KIRKIZLAR, M. A. DEMIR, Okült Malignite, Antikoagulasyon ve Kanama Yönleri ile Splanknik Venöz Tromboza Bakis, Ulusal Hematoloji Kongresi 2017, Antalya-TÜRKIYE.

.M. BAYSAL, G. E. ÜMIT, S. BAYSAL, O. H. KIRKIZLAR, M. A. DEMIR, Multiipl Myelom Hastalarinda M Proteini ve Kardiyak Fonksiyonlarin Iliskisi, Ulusal Hematoloji Kongresi 2017, ANTALYA-TÜRKIYE.

.B. H. ARBAK, M. BAYSAL, G. E. ÜMIT, O. H. KIRKIZLAR, M. A. DEMIR, Rituksimab Kullanimi Sonrasi elisen Bronsiolitis Oblliterans Organize Pnömonisi Olgu Sunumu, Ulusal Hematoloji Kongresi 2017, Antalya-TÜRKIYE.

.B. D. ESEN, M. BAYSAL, G. E. ÜMIT, O. H. KIRKIZLAR, M. A. DEMIR, Faktör VII Eksikligi Oan bir Gebenin Yönetimi, Ulusal Hematoloji Kongresi 2017, Antalya-TÜRKIYE.

.B. I. BOZ, M. BAYSAL, M. A. DEMIR, G. E. ÜMIT, O. H. KIRKIZLAR, Hodgkin Lenfoma Iliskili Vanishing Bile duct Sendromu, Ulusal Hematoloji Kongresi 2017, Antalya-TÜRKIYE.

.M. BAYSAL, G. E. ÜMIT, S. BAYSAL, O. H. KIRKIZLAR, M. A. DEMIR, Philadelphia Negatif Kronik Myeloproliferatif Hastaliklarda MPN-10 Semptom Degerlendirme Ölçegi ve Bulgular ile Iliskisi, Ulusal Hematoloji Kongresi 2017, Antalya-TÜRKIYE.

.G. E. ÜMIT, M. BAYSAL, M. A. DEMIR, Akut Myeloid Lösemi Hastalarinda Kirilganlik, Kronolojik Yas Kavraminin Algisal Yanilticiligi, Ulusal Hematoloji Kongresi 2017, Antalya-TÜRKIYE.

.M. KUDAY, M. BAYSAL, G. E. ÜMIT, O. H. KIRKIZLAR, M. A. DEMIR, Akut Myeloid Lösemi Seyrinde Gelisen bir Septik Artrit Olgusu, Ulusal Hematoloji 2017, Antalya-TÜRKIYE.

.F. A. DOGAN, M. BAYSAL, G. E. ÜMIT, O. H. KIRKIZLAR, M. A. DEMIR, Kronik Lenfositer Lösemi ve Primer Biliyer Siroz: Olgu Sunumu, Ulusal Hematoloji Kongresi 2017, Antalya-TÜRKIYE.

.G. E. ÜMIT, M. BAYSAL, O. H. KIRKIZLAR, M. A. DEMIR, REMISYON INDÜKSIYONU TEDAVISI ALAN AKUT MYELOIDLÖSEMI HASTALARINDA POSAKONAZOL PROFILAKSISININDOGRUDAN MALIYET ANALIZI, Ulusal Hematoloji Kongresi 2018, -TÜRKIYE.

.T. ISPIR, S. YILMAZ, A. KUNT, S. ISPIR, A. TÜRER, M. A. DEMIR, ATEROSKLEROZ HASTALARINDA SERUM MIRNA221 DÜZEYI VE HEMOSTAZ ARASINDAKI ILISKININ BELIRLENMESI, 42. ULUSAL HEMATOLOJI KONGRESI, -TÜRKIYE.

.E. ÜMIT, M. BAYSAL, Y. DURMUS, M. A. DEMIR, KRONIK LENFOSITIK LÖSEMI DE CD11C EKSPRESYONU KOMPLIKASYONLAR VE SAGKALIM ILE ILISKISI, 42. UKUSAL HEMATOLOJI KONGRESI, -TÜRKIYE.

MULTİPL MYELOM HASTALARININ TIP DIŞI YARDIMA YAKLAŞIMLARI. Elif Gülsüm Ümit, Elif Mutlu, Ahmet Muzaffer Demir. 41. Ulusal Hematoloji Kongresi, Abstract: 526 P-333 (October 2015)

İMMÜN TROMBOSİTOPENİ TEDAVİSİNE BAĞLI KÜÇÜK ARTER TROMBOZU GELİŞEN BİR OLGU. Muhammet Maden, Volkan Baş, Ali Gökyer, Hasan Göze, Ahmet Muzaffer Demir. 41. Ulusal Hematoloji Kongresi Abstract: 540 P-312 (October 2015)

PARAPROTEİNEMİLİ OLGULARIN GERİYE DÖNÜK DEĞERLENDİRMESİ. Ahmet Küçükarda, Elif Gülsüm Ümit, Mehmet Şevki Uyanık, Gülsüm Emel Pamuk, Ahmet Muzaffer Demir. 41. Ulusal Hematoloji Kongresi Abstract: 550 P-258 (October 2015)

KRONİK LENFOSİTİK LÖSEMİ SEYRİNDE GÖRÜLEN KANSER TİPLERİ: BİR OLGU SUNUMU. Mehmet Murat Zerey, Elif Gulsum Ümit, Ebru Taştekin, Hakan Gürkan, Ahmet Muzaffer Demir. 41. Ulusal Hematoloji Kongresi, Abstract: 548 P-149 (October 2015)

MULTİPL MYELOMLU HASTALARDA TROMBOZ SIKLIĞI: GERİYE DÖNÜK TEK MERKEZ ÇALIŞMASI. Elif Gülsüm Ümit, Murat Zerey, Muhammet Maden, Ahmet Muzaffer Demir. 41. Ulusal Hematoloji Kongresi, Antalya. Sözlü sunu. Abstract: 503 TP-084 (October 2015)

TRAKYA ÜNİVERSİTESİ TIP FAKÜLTESİ HEMATOLOJİ BİLİM DALI KLİNİĞİNDEKİ VANKOMİSİN DİRENÇLİ ENTEROKOK KOLONİZASYONU VE İLİŞKİLİ ETMENLER: 2015 YILI GÜNCELLEMESİ. Elif Gülsüm Ümit, Figen Kuloglu, Ahmet Muzaffer Demir. 41. Ulusal Hematoloji Kongresi, Antalya. Sözlü sunu Abstract: 503 TP-084 (October 2015)

TRAKYA BÖLGESİNDEKİ HEMATOLOJİK HABİS HASTALIKLARIN DEMOGRAFİK ÖZELLİKLERİNİN DEĞERLENDİRİLMESİ. Yusuf Şapuk, Ali Cem Yekdeş, Elif Gülsüm Ümit, Volkan Baş, Ahmet Muzaffer Demir. 41. Ulusal Hematoloji Kongresi, Antalya. Sözlü sunu. Abstract: 500 SS-072 (October 2015)

DİFFÜZ BÜYÜK B HÜCRELİ LENFOMA HASTALARINDA GENEL SAĞKALIMI ÖNGÖRMEDE PROGNOZ SKORLARININ KARŞILAŞTIRILMASI. Muhammet Maden, Ahmet Muzaffer Demir, Mehmet Şevki Uyanık, Ali Gökyer, Volkan Baş, Elif Gülsüm Ümit, Fulya Öz Puyan, Gülsüm Emel Pamuk. 41. Ulusal Hematoloji Kongresi, Antalya. Sözlü sunu Abstract: 544 SS-046 (October 2015)

Gaucher hastalığında pulmoner hipertansiyon: Ekokardiyografi mi? Sağ kalp kateterizasyonu mu? Çelik M, Aytürk S, Yılmaztepe M, Küçükarda A, Mert O, Güldiken S, Demir, AM, Tuğrul A. 37. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi 6-10 Mayıs 2015 Antalya. P136 (May 2015)

Pamuk GE, Uyanık MŞ, Karaca T, Demirtaş S, Demir AM, Pamuk ÖN. İmmün trombositopenide fostamatinib dalağa T lenfosit migrasyonunu azaltarak etki etmektedir. 40. Ulusal Hematoloji Kongresi, SS-068 Türk Hematoloji Derneği, 22-25 Ekim 2014, Titanic Kongre Merkezi, Antalya

Uyanık MŞ, Pamuk GE, Baysal M, Maden M, Ümit EG, Demir AM. Esansiyel trombositoz ve polisitemia vera tanılı hastalarda JAK2V617F allel yükü ile tromboz arasındaki ilişki. 40. Ulusal Hematoloji Kongresi, SS-053 Türk Hematoloji Derneği, 22-25 Ekim 2014, Titanic Kongre Merkezi, Antalya

Uyanık MŞ, Maden M, Ümit EG, Kurt İ, Özpuyan F, Pamuk GE, Demir AM. Myelodislastik sendrom tanılı hastalarda prognoz değerlendirmesi. 40. Ulusal Hematoloji Kongresi, SS-016 Türk Hematoloji Derneği, 22-25 Ekim 2014, Titanic Kongre Merkezi, Antalya

Ümit EG, Uyanık MŞ, Ermiş V, Tuncer S, Gürkan H, Öz Puyan F, Pamuk GE, Demir AM. Philadelphia negatif myeloproiferatif hastalıklar seyrinde ateroskleroz ve ilişkili faktörlerin değerlendirmesi. 40. Ulusal Hematoloji Kongresi, TP-035 Türk Hematoloji Derneği, 22-25 Ekim 2014, Titanic Kongre Merkezi, Antalya

Uyanık MŞ, Gürkan H, Eren T, Asaoğlu V, Maden M, Ümit EG, Pamuk GE, Demir AM. Trakya bölgesinde görülen alfa talasemi gen anormalliklerinin klinik üzerine etkileri. 40. Ulusal Hematoloji Kongresi, TP-016 Türk Hematoloji Derneği, 22-25 Ekim 2014, Titanic Kongre Merkezi, Antalya

Ümit EG, Demir M, Uyanık Ş, Maden M, Tokuç B, Puyan F, Pamuk GE. İleri yaş akut myeloid lösemi hastalarında mortlite ve ilişkili faktörlerin değerlendirmesi. 40. Ulusal Hematoloji Kongresi, TP-003 Türk Hematoloji Derneği, 22-25 Ekim 2014, Titanic Kongre Merkezi, Antalya

Hacibekiroglu T, Maden M, Albayrak İ, Tarladaçalışır T, Uyanık MŞ, Öz Puyan F, Demir M.Yaygın kemik tutulumu ile başvuran ileri evre klasik Hodgkin lenfoma olgusu. 40. Ulusal Hematoloji Kongresi, P-273 Türk Hematoloji Derneği, 22-25 Ekim 2014, Titanic Kongre Merkezi, Antalya

Gökyer A, Baysal M, Uyanık MŞ, Ümit EG, Taştekin E, Demir AM. Dalak rüptürü ve hemofagositik sendromla seyreden primer dalak diffüz büyük B hücreli lenfoması. 40. Ulusal Hematoloji Kongresi, P-268 Türk Hematoloji Derneği, 22-25 Ekim 2014, Titanic Kongre Merkezi, Antalya

Ümit EG, Öz Puyan F, Demir AM. Siklik trombositopeni ile seyreden edinsel amegakaryositik trombositopeni olgusu. 40. Ulusal Hematoloji Kongresi, P-145 Türk Hematoloji Derneği, 22-25 Ekim 2014, Titanic Kongre Merkezi, Antalya

Uyanık MŞ, Baysal M, Asoğlu V, Maden M, Ümit EG, Turgut B, Pamuk GE, Demir AM. Akış sitometrisinin klinik tanı ve izlemde kullanımı: Tek merkez deneyimi. 40. Ulusal Hematoloji Kongresi, P-059 Türk Hematoloji Derneği, 22-25 Ekim 2014, Titanic Kongre Merkezi, Antalya

Yılmaz G, Üstündağ S, Temizöz O, Süt N, Demir M, Ermiş V, Sevinç C, Üstündağ A. Kronik böbrek hastalığı sürecinde fibroblast büyüme faktörü 23 ateroskleroz gelişiminde etkili mi? 16. Ulusal Hipertansiyon ve Böbrek Hastalıkları Kongresi, 21-25 Mayıs 2014 Kaya Palazzo Hotel, Antalya

Mehmet Şevki Uyanık, Elif Gülsüm Ümit, Muhammet Maden, Veysel Özcan, Yusuf Şapuk, Ahmet Muzaffer Demir. Doğum sonrası dönemde faktör VIII inhibitör gelişimi: Bir edinsel hemofili A olgusu. 39. Ulusal Hematoloji Kongresi 23-26 Ekim 2013, Antalya, Abstract:0517 [P-148] (October 2013)

Elif Gülsüm Ümit, Mehmet Şevki Uyanık, Figen Kuloğlu, Ahmet Muzaffer Demir. Virgibacillus pantothenticus, bir akut lösemi hastasında sepsis, karaciğer ve kas abseleri etkeni. 39. Ulusal Hematoloji Kongresi 23-26 Ekim 2013, Antalya, Abstract:0542 [P-076] (October 2013)

Elif Gülsüm Ümit, Mehmet Şevki Uyanık, Yahya Çelik, Ahmet Muzaffer Demir. Dirençli KLL seyrinde gelişen ikincil malinite ve progresif multifokal lökoensafalopati. 39. Ulusal Hematoloji Kongresi 23-26 Ekim 2013, Antalya Abstract:0544 [P-070] (October 2013)

Elif Gülsüm Ümit, Sinem Azizoğlu, Mehmet Şevki Uyanık, Muhammet Maden, Atakan Sezer, Ahmet Muzaffer Demir. Hematolojik nedenli splenektomili olguları: Tek merkez deneyimi. 39. Ulusal Hematoloji Kongresi 23-26 Ekim 2013, Antalya, Abstract:0595 [TP-47] (October 2013)

Mehmet Şevki Uyanık, Muhammet Maden, Elif Gülsüm Ümit, Esma Nur Demir, Gülsüm Emel Pamuk, Ahmet Muzaffer Demir. Hemoglobin elektroforezlerinin geriye dönük değerlendirilmesi: Tek merkez deneyimi. 39. Ulusal Hematoloji Kongresi 23-26 Ekim 2013, Antalya, Abstract:0570 [S-70] (October 2013)

Mehmet Şevki Uyanık, Elif Gülsüm Ümit, Muhammet Maden, Kübra Saçar, Hakan Gürkan, Gülsüm Emel Pamuk, Ahmet Muzaffer Demir. Miyelodisplastik sendrom tanılı hastaların klinik özelliklerinin değerlendirilmesi: Tek merkez deneyimi. 39. Ulusal Hematoloji Kongresi 23-26 Ekim 2013, Antalya, Abstract:0546 [S-17] (October 2013)

Mehmet Şevki Uyanık, Elif Gülsüm Ümit, Muhammet Maden, Kübra Saçar, Hakan Gürkan, Gülsüm Emel Pamuk, Ahmet Muzaffer Demir. Miyelodisplastik sendrom tanılı hastaların konvansiyonel sitogenetik özelliklerinin değerlendirilmesi: Tek merkez deneyimi. 39. Ulusal Hematoloji Kongresi 23-26 Ekim 2013, Antalya, Abstract:0543 [S-15] (October 2013)

Gülsüm Emel Pamuk, Mehmet Şevki Uyanık, Elif Gülsüm Ümit, Muhammet Maden, Ahmet Muzaffer Demir. Mide tutulumu ile giden lenfomaların değerlendirilmesi: tek merkez deneyimi. 39. Ulusal Hematoloji Kongresi 23-26 Ekim 2013, Antalya, Abstract:0501 [S-09] (October 2013)

Vardar SA, Karaca A, Güldiken S, Demir M. Anaerobik egzersizin insülin direnci ve vücut kompozisyonuna etkisi. 39. Ulusal Fizyoloji Kongresi, Türk Fizyolojik Bilimler Derneği, Hacettepe Üniversitesi Kültür Merkezi,2013, Ankara, P133

National Conferences and Symposiums

12. Ulusal Hemofili Kongresinde düzenleme kurulu üyesi, 16-19 Nisan 2015 Antalya (April 2015)

Koagülasyon sistemi ve Hemofili ile ilgili testlerin rasyoneli. 11. Uludağ İç Hastalıkları Kış Kongresi 08-11 Mart 2015 (March 2015)

4. Ulusal Geriatrik Hematoloji Kongresinde oturum başkanlığı 02-04 Ekim 2015

Kongre Başkanı, 9. Ulusal Tromboz, Hemostaz ve Anjioloji Kongresi ve 1. Herkes için hemostaz kursu, 6-8 Mart 2015, Florence Nightingale Hastanesi, Şişli İstanbul

Oturum başkanlığı, Edinsel Hemofili Oturumu, Hemofili Vakalarla Eğitim sempozyumu, 6-8 Şubat 2015, Barut Hotel Lara Antalya

Oturum başkanlığı, 5. Ulusal Hücrsel Tedavi ve Rejeneratif Tıp Kongresi, 27 Şubat-1 Mart 2015, Dicle Üniversitesi Kongre Merkezi, Diyarbakır

Pıhtılaşma sistemi ve kanamalı hastalıklar, Türk Hematoloji Derneği, İlaç Endüstrisinde Çalışanlar İçin Hematoloji Eğitimi Programı-7, 10 Ocak 2015, Nov Otel İstanbul.

Fibrinolitik Sisteme Genel Bakış, 9. Ulusal Tromboz, Hemostaz ve Anjioloji Kongresi ve 1. Herkes için hemostaz kursu, 6-8 Mart 2015, Florence Nightingale Hastanesi, Şişli İstanbul

Sekonder Hemostaza Genel Bakış, 9. Ulusal Tromboz, Hemostaz ve Anjioloji Kongresi ve 1. Herkes için hemostaz kursu, 6-8 Mart 2015, Florence Nightingale Hastanesi, Şişli İstanbul

Demir AM. Multipl Myelomda tromboprofilaksi. 2. Akdeniz Hematoloji Sempozyumu 3-5 Nisan 2015, Titanic Beach Lara Antalya.

Ekiz-Bilir B, Soysal-Atile N, Bilir B, Güldiken S, Demir AM, Tuğrul A. Hipotiroidi hastalarında RPB4 (retinol binding protein-4) düzeylerinin değerlendirmesi. 36. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi, 21-25 Mayıs 2014, Cornelia Diamond Hotel, Antalya.

Kongre Sekreteri, 8. Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavileri Kongresi, Türk Hematoloji Derneği, 6-8 Mart 2014, Xanadu Kongre Merkezi, Belek, Antalya

Kongre Sekreteri, 40. Ulusal Hematoloji Kongresi, Türk Hematoloji Derneği, 22-25 Ekim 2014, Titanic Kongre Merkezi, Antalya

Kongre Başkanı, 8. Ulusal Tromboz, Hemostaz ve Anjioloji Kongresi, 9 Mayıs 2014, Florence Nightingale Hastanesi, Şişli İstanbul

Eozinofiliye yaklaşım oturumu, 16. Ulusal İç Hastalıkları Kongresi, 16-18 Ekim 2014, Titanic Deluxe Kongre Merkezi, Antalya

Özel durumlarda anemi oturumu, 16. Ulusal İç Hastalıkları Kongresi, 16-18 Ekim 2014, Titanic Deluxe Kongre Merkezi, Antalya

Akılcı İlaç Kullanımı Oturumu, 8. Ulusal Kemik İliği Transplantasyonu ve Kök Hücre Tedavileri Kongresi, Türk Hematoloji Derneği, 6-8 Mart 2014, Xanadu Kongre Merkezi, Belek, Antalya

İnhibitör Mercek Altında Oturumu, 11. Uluslararası Türkiye Hemofili Kongresi, 17-20 Nisan 2014, Polat Rönesans Hotel, İstanbul

Hematoloji Oturumu, Trakya İç Hastalıkları Günleri, Trakya Üniversitesi Balkan Kongre Merkezi, 30 Mayıs-1 Haziran 2014, Edirne

TSH/ISTH Ortak Oturumu, 40. Ulusal Hematoloji Kongresi, Türk Hematoloji Derneği, 22-25 Ekim 2014, Titanic Kongre Merkezi, Antalya

Erişkin beta talasemisinde izlem ve yönetim, 1. Talasemi ve Hemoglobinopatiler Kongresi, 20-23 Kasım 2014, Çeşme Sheraton Otel Kongre Merkezi, İzmir

Antikoagülan kullanımına bağlı kanamaların yönetimi, 16. Ulusal İç Hastalıkları Kongresi, 16-18 Ekim 2014, Titanic Deluxe Kongre Merkezi, Antalya

Erişkin hemofilik hstalarda karşılaşılan sorunlar, 8. Ulusal Tromboz, Hemostaz ve Anjioloji Kongresi ve 1. Herkes için hemostaz kursu, 9 Mayıs 2014, Florence Nightingale Hastanesi, Şişli İstanbul

Fibrinolitik Sistem Fizyolojisi, Klinik tablolar ve Laboratuvar ilişkisi, Klnik Biyokimya Uzmanları Derneği, Uluslararası katılımlı kongre ve laboratuvar expo 2014. 16-20 Eylül 2014 Sheraton Çeşme Hotel İzmir,

Kongre Sekreteri, 39. Ulusal Hematoloji Kongresi, 23-26 Ekim 2013, Titanic Deluxe Otel, Antalya (October 2013)

Demir M. Erişkinde profilaksi. Erişkin Hemofili Çalıştayı, 10. Ulusal Hemofili Kongresi 14-17 Nisan 2013 Sheraton Oteli Kongre Merkezi, Çeşme-İzmir (October 2013)

Demir M. Koagülasyon defektli hastaya yaklaşım. 15. Ulusal İç Hastalıkları Kongresi, 2-6 Ekim 2013, Titanic Deluxe Otel, Antalya. (October 2013)

Demir M. Hemofilinin değişen yüzü, 39. Ulusal Hematoloji Kongresi 23-26 Ekim 2013, Titanic Deluxe Otel, Antalya (October 2013)

Talasemi İntermedia’da Komplikasyonlar Oturumu, Transfüzyon bağımlı olmayan talasemi intermedia (NTDT) Sempozyumu, Talasemi Eğitim Araştırma ve Uygulama Derneği, 8.06.2103 Kalyon Hotel İstanbul (June 2013)

Demir M. Erişkin Hemofili Çalıştayı, 10. Ulusal Hemofili Kongresi 14-17 Nisan 2013 Sheraton Oteli Kongre Merkezi, Çeşme-İzmir (April 2013)

Demir M. Ortopedik cerrahide oran antikoagülanlar ve tromboprofilaksi. 11. Osteoporoz, Osteoartrit Eklem Cerrahisi Kongresi, 19-23 Nisan 2013, Royal Holiday Palace Lara Antalya (April 2013)

National Books and Book Chapters

Bir Avuç Kanbilimciye Saygı İle, KANBİLİMCİLER İLE SÖYLEŞİLER-2 (October 2024)

Hematolojik Hastalıklar, Kısım Editörleri: Kırkızlar O, Demir AM, Eds: İliçin G, Biberoğlu K, Süleymanlar G, Ünal S. ; İç Hastalıkları Kitabı 2 Cilt, 4. Baskı. Güneş Kitabevi, Ankara, 2024

Adıgüzel C, Ümit EG, Demir AM. Pıhtılaşma bozuklukları. Eds: İliçin G, Biberoğlu K, Süleymanlar G, Ünal S., İç Hastalıklar Kitabı 2 cilt, 4. Baskı, Ankara Güneş Kitabevi, Ankara, 2024, P: 1620-1644.

Baş V, Demir AM. Akut Lösemiler. Eds: İliçin G, Biberoğlu K, Süleymanlar G, Ünal S., İç Hastalıklar Kitabı 2 cilt, 4. Baskı, Ankara Güneş Kitabevi, Ankara, 2024, P: 1578-1581.

Gülsaran Karaman S, Demir AM. Kronik lenfositik lösemiler Eds: İliçin G, Biberoğlu K, Süleymanlar G, Ünal S., İç Hastalıklar Kitabı 2 cilt, 4. Baskı, Ankara Güneş Kitabevi, Ankara, 2024, P: 1555-1559.

Alp Kırkızlar T, Demir AM. Eritrositoz ve polisitemiler. Eds: İliçin G, Biberoğlu K, Süleymanlar G, Ünal S., İç Hastalıklar Kitabı 2 cilt, 4. Baskı, Ankara Güneş Kitabevi, Ankara, 2024, P: 1545-1547.

Baysal M, Demir AM. Lökositoz ve lökomoid reaksiyonlar. Eds: İliçin G, Biberoğlu K, Süleymanlar G, Ünal S., İç Hastalıklar Kitabı 2 cilt, 4. Baskı, Ankara Güneş Kitabevi, Ankara, 2024, P: 1543-1544.

Baysal M, Demir AM. Nötrofiller ve mononükleer fagositik hücreler. Eds: İliçin G, Biberoğlu K, Süleymanlar G, Ünal S., İç Hastalıklar Kitabı 2 cilt, 4. Baskı, Ankara Güneş Kitabevi, Ankara, 2024, P: 1536-1538.

Demirci U, Demir AM. Aplastik anemi ve kemik iliği yetmezliği sendromları. Eds: İliçin G, Biberoğlu K, Süleymanlar G, Ünal S., İç Hastalıklar Kitabı 2 cilt, 4. Baskı, Ankara Güneş Kitabevi, Ankara, 2024, P: 1497-1498.

Geleneksel pıhtılaşma testleri ve klinik kullanımdaki yeri. Ahmet Muzaffer Demir, Klinik Biyokimya, Eds: Nesrin Emekli-Türkan Yiğitbaşı, Nobel Tıp Kitabevleri Tic. Ltd. Sti. İstanbul, ISBN: 978-605-84521-0-7, pp.323-331

Bölüm Çevirisi Yazarlığı, Elif Uğur Ümit, Ahmet Muzaffer Demir, Board sınavı denemesi, Bölüm 67, pp 880-941, Cleveland Klinik İç Hastalıkları 5. Baskı Çeviri Ed. Prof. Dr. Ahmet Muzaffer Demir, ISBN-978-605-4499-98-4 2014 İstanbul Tıp Kitabevi, İstanbul Medikal Sağlık ve Yayıncılık Hiz. Ltd. Sti. Çapa-İstanbul

Bölüm Çevirisi Yazarlığı, Mehmet Şevki Uyanık, Ahmet Muzaffer Demir, Palyatif Tıp: İç hastalıkları uzmanlarının bilmeleri gerekenler, Bölüm 27, pp 325-336, Cleveland Klinik İç Hastalıkları 5. Baskı Çeviri Ed. Prof. Dr. Ahmet Muzaffer Demir, ISBN-978-605-4499-98-4 2014 İstanbul Tıp Kitabevi, İstanbul Medikal Sağlık ve Yayıncılık Hiz. Ltd. Sti. Çapa-İstanbul

Bölüm Çevirisi Yazarlığı, Mehmet Şevki Uyanık, Ahmet Muzaffer Demir, Hücre morfolojisinin gözden geçirilmesi, Bölüm 26, pp 314-324, Cleveland Klinik İç Hastalıkları 5. Baskı Çeviri Ed. Prof. Dr. Ahmet Muzaffer Demir, ISBN-978-605-4499-98-4 2014 İstanbul Tıp Kitabevi, İstanbul Medikal Sağlık ve Yayıncılık Hiz. Ltd. Sti. Çapa-İstanbul

Bölüm Çevirisi Yazarlığı, Mehmet Şevki Uyanık, Ahmet Muzaffer Demir, Plazma Hücre Bozuklukları, Bölüm 25, pp 307-313, Cleveland Klinik İç Hastalıkları 5. Baskı Çeviri Ed. Prof. Dr. Ahmet Muzaffer Demir, ISBN-978-605-4499-98-4 2014 İstanbul Tıp Kitabevi, İstanbul Medikal Sağlık ve Yayıncılık Hiz. Ltd. Sti. Çapa-İstanbul

Bölüm Çevirisi Yazarlığı, Mehmet Şevki Uyanık, Ahmet Muzaffer Demir, Lenfoma, Bölüm 24, pp 302-307, Cleveland Klinik İç Hastalıkları 5. Baskı Çeviri Ed. Prof. Dr. Ahmet Muzaffer Demir, ISBN-978-605-4499-98-4 2014 İstanbul Tıp Kitabevi, İstanbul Medikal Sağlık ve Yayıncılık Hiz. Ltd. Sti. Çapa-İstanbul

Bölüm Çevirisi Yazarlığı, Mehmet Şevki Uyanık, Ahmet Muzaffer Demir, Anemi, Bölüm 22, pp 284-293, Cleveland Klinik İç Hastalıkları 5. Baskı Çeviri Ed. Prof. Dr. Ahmet Muzaffer Demir, ISBN-978-605-4499-98-4 2014 İstanbul Tıp Kitabevi, İstanbul Medikal Sağlık ve Yayıncılık Hiz. Ltd. Sti. Çapa-İstanbul

Bölüm Çevirisi Yazarlığı, Mehmet Şevki Uyanık, Ahmet Muzaffer Demir, Trombosit ve pıhtılaşma bozuklukları, Bölüm 21, pp 264-284, Cleveland Klinik İç Hastalıkları 5. Baskı Çeviri Ed. Prof. Dr. Ahmet Muzaffer Demir, ISBN-978-605-4499-98-4 2014 İstanbul Tıp Kitabevi, İstanbul Medikal Sağlık ve Yayıncılık Hiz. Ltd. Sti. Çapa-İstanbul

Bölüm Çevirisi Yazarlığı, Mehmet Şevki Uyanık, Ahmet Muzaffer Demir, Lösemi, Bölüm 20, pp 255-264, Cleveland Klinik İç Hastalıkları 5. Baskı Çeviri Ed. Prof. Dr. Ahmet Muzaffer Demir, ISBN-978-605-4499-98-4 2014 İstanbul Tıp Kitabevi, İstanbul Medikal Sağlık ve Yayıncılık Hiz. Ltd. Sti. Çapa-İstanbul

Konuk Editör, Hematolog Dergisi, (Türk Hematoloji Derneği), 2014; 4(3): 381-592 (ISSN: 2146-6408)

Çeviri Editörlüğü, Wintrobe’un Klinik Hematoloji Atlası, Çeviri Ed. Teoman Soysal, Hale Ören, Ahmet Muzaffer Demir, İbrahim C. Haznedaroğlu, Fahir Özkalemkaş, A. Zahit Bolaman, Mehmet Sönmez, ISBN-978-605-4499-88-5 2014 İstanbul Tıp Kitabevi, İstanbul Medikal Sağlık ve Yayıncılık Hiz. Ltd. Sti. Çapa-İstanbul

Çeviri Editörlüğü, Cleveland Klinik İç Hastalıkları 5. Baskı Çeviri Ed. Prof. Dr. Ahmet Muzaffer Demir, ISBN-978-605-4499-98-4 2014 İstanbul Tıp Kitabevi, İstanbul Medikal Sağlık ve Yayıncılık Hiz. Ltd. Sti. Çapa-İstanbul

Soysal T, Ören H, Demir M, Haznedaroğlu İC, Özkalemkaş F, Bolaman Z, Sönmez M. Wintrobe’un Klinik Hematoloji Atlası, Eds. Tkachuck DC, Hirschmann JV. İstanbul Tıp Kitapevleri İstanbul 2013 ISBN: 978-605-4499-88-5

Soysal T, Ören H, Demir M, Haznedaroğlu İC, Özkalemkaş F, Bolaman Z, Sönmez M, Arat M. Hematopoeitik Kök Hücre Transplantasyonu EBMT El Kitabı Eds. Apperley J, Carreras E, Gluckman E, Masszi T. Türk Hematoloji Derneği Yayınları 2013, ISBN: 978-605-64320-0-2 (Çeviri editörlüğü)

Soysal T, Ören H, Demir M, Haznedaroğlu İC, Özkalemkaş F, Bolaman Z, Sönmez M. Kan hastalıklarının patofizyolojisi. Eds. Bunn HF, Aster JC. Lange Tıp Kitapları İstanbul Tıp Kitabevleri İstanbul 2013 ISBN: 978-605-4499-54-0

Hematolojik Hastalıklar, Kısım Editörleri: Kırkızlar O, Demir AM; İç Hastalıkları Kitabı, Eds: İliçin G, Biberoğlu K, Süleymanlar G, Ünal S. Güneş Kitabevi, Ankara, 2023

Doctoral Dissertations Advised

VENÖZ TROMBOEMBOLİZM TANILI HASTALARIN DEMOGRAFİK ÖZELLİKLERİNİN VE RİSK FAKTÖRLERİNİN GERİYE DÖNÜK DEĞERLENDİRİLMESİ- Uzm. Dr. Güray Aygün

TRAKYA ÜNİVERSİTESİ SAĞLIK ARAŞTIRMA VE UYGULAMA MERKEZİNDE TAKİP EDİLEN AKUT MİYELOİD LÖSEMİ TANILI HASTALARIN RETROSPEKTİF GERİYE DÖNÜK İNCELEMESİ- Uzm. Dr. Faruk Yıldız

Yusuf Şapuk, İç Hastalıkları Uzmanlık tezi, 2008-2012 yılları arasında tanı konulan hematolojik habis hastalıkların demografik geriye dönük incelenmesi

Ahmet Küçükarda, İç Hastalıkları Uzmanlık tezi, 2015, Paraproteinemli olguların geriye dönük değerlendirilmesi

İç Hastalıkları Uzmanlık Öğrencisi, Dr. Yusuf Şapuk

Editorial Positions

Turkish Journal of Hematology, Yardımcı Editör
Clinical and Applied Thrombosis/hemostasis, 2015 Akdeniz Bölge Editörü
Clinical & Applied Thrombosis and Hemostasis, Mediterranean Editör
Turkish Journal of Hematology, Editör Yardımcılığı, 2014
Turkish Journal of Hematology, Editör Yardımcılığı
Clinical applied Thrombosis and Hemostasis, Akdeniz Bölge Editörlüğü –Editör Yardımcılığı

Referee Positions

2024-02-26 Therapeutic Advances in Hematology (February 2024)

Tıp Eğitimi Dünaysı (Dergipark) 1410827 - "EVALUATION OF THE TENDENCY OF MEDICAL FACULTY TERM 1 AND TERM 5 STUDENTS TO MIGRATE ABROAD"

Thrombosis Research Ref.: Ms. No. TR-D-24-00098R1 Complications associated to Midline- and Long-Peripheral-Catheters in Adults. Systematic Review of Literature and Recommendations for Clinical Research.

Doç. Dr. Volkan İNAL Trakya Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı ataması, 12.01.2016 (January 2016)

41. Ulusal hematoloji Kongresi Kongre sekreterliği, 22-25 Ekim 2015 Antalya
Turkish Journal of Hematology-5 adet
Clinical Applied thrombosis and Hemostasis- 10 adet

Doç. Dr. Mustafa ORAN Namık Kemal Üniversitesi Tıp Fakültesi İç Hastalıkları Anabilim Dalı na atama

Projects

.Yüksekögretim Kurumlari tarafindan destekli bilimsel arastirma projesi, Immun trombositopenide lenfosit kemoatraktan düzeylerinin degerlendirilmesi,, Immun trombositopeni patogenezinde inflmasyonun rolü ve lenfosit kemoatraktalarin yerinin saptanmasi amaçlanmistir, Baslangiç Tarihi: 27.03.2017, Bitis Tarihi : ,Kurumu: TRAKYA ÜNIVERSITESI, Devam Ediyor.

.Yüksekögretim Kurumlari tarafindan destekli bilimsel arastirma projesi, Immun trombositopenide monosit kemoatraktan düzeylerinin degerlendirilmesi, Trakya Üniv. Bilimsel Arastirma Projesi, Immun trombositopeni patogenezinde inflamasyon parametrelerinin rolü ve monosit kemoatraktanlarin yerinin saptanmasi amaçlanmakatadir., Baslangiç Tarihi: 27.03.2017, Bitis Tarihi : ,Kurumu: TRAKYA ÜNIVERSITESI, Devam Ediyor.

.Yüksekögretim Kurumlari tarafindan destekli bilimsel arastirma projesi, Trakya Üniversitesi Tip fakültesi Ulusal tip Egitimi Akreditasyon Hazirlik Projesi, Trakya Üniv. Bilimsel Arastirma Projesi, 2017/187, Tip Fakültesi mezuniyet öncesi egitim programinin ulusal tip egitimi akreditasypn kurulu tarafindan akredite edilmesi için gerekli olan tüm asamalarin incelenmesi ve hazirlik yapilmasi kapsaminda yapilacak çalismalarin yapilmasi amaçlanmistir., Baslangiç Tarihi: 24.10.2017, Bitis Tarihi : ,Kurumu: TRAKYA ÜNIVERSITESI, Devam Ediyor.

.TÜBITAK PROJESI, Koagülasyon yolaklarinin degerlendirilmesi için tasinabilir tromboelestometri cihazinin gelistirilmesi, Baslangiç Tarihi: 04.11.2015, Bitis Tarihi : ,Kurumu: TRAKYA ÜNIVERSITESI, Devam Ediyor.

Other

Doçentlik Ataama Jürisi Hakkı Onur Kırkızlar

.M. A. DEMIR, Tip Fakültesi Ögrencileri Için Tip Egitimi, Ulusal, Bölüm: Program Akreditasyonu ve Degerlendirmesi-Tip Egitimi, Basim Türü: Basili, pp. 79-82, TÜRKIYE-Malatya, ISBN978-975-8573-51-6, Inönü Üniversitesi Yayinevi, 20191. Basim.

.K. R. KAVAKLI, C. BALKAN, M. A. DEMIR, C. M. AR, B. O. ZÜLFIKAR, A. O. KÜPESIZ, H. ÖREN, HEMOFILI: ULUSAL TANI VE TEDAVI KILAVUZU - 2017, Ulusal, Basim Türü: Basili, TÜRKIYE-Istanbul, ISBN978-605-87057-0-8, GALENOS KITABEVI - TÜRK HEMATOLOJI DERNEGI, 20171000. Basim.

.M. A. DEMIR, H. ÖNGEN, D. TURAL, Kanserle Iliskili Venöz Tromboembolizm Profilaksi Tani ve Tedavi KIlavuzu, Ulusal, Basim Türü: Basili+Elektronik, TÜRKIYE-Istanbul, ISBN978-605-5720-15-5, Cortex Iletisim Hizmetleri A.S. Besiktas-Istanbul, 20161. Basim.

.M. A. DEMIR, Klinik Biyokimya, Ulusal, Bölüm: Geleneksel pihtilasma testleri ve klinik uygulamalardaki yeri, Basim Türü: Basili, pp. 323-331, TÜRKIYE-Istanbul, ISBN978-605-84521-0-7, Nobel Tip Kitabevleri, 20151. Basim.

Doç. Dr. Filiz Vural, Ege Üniversitesi ProfesörlükvAtaması,Mart 2015
Doç. Dr. Ramazan Esen, Van Yüzüncü Yıl Üniversitesi Doçentlik Ataması, Ocak 2014
Doç. Dr. Sernaz Uzunoğlu, Trakya Üniversitesi Doçentlik Ataması, Nisan 2014

.M. A. DEMIR, 9 Cecil Textbook of Medicine Cilt 1 2, Ulusal , ISBNTakim 978-975-277-339-4., Günes Kitabevleri, Ankara,, 2011.

.M. A. DEMIR, 3 Türk Hematoloji Dernegi Ulusal Tani ve Tedavi Kilavuzu 2010, Ulusal , Eflatun Basin Dagitim ve Yayincilik Danismanlik Yatirim ve Tic Ltd. Sti. Ankara, 2010.

.M. A. DEMIR, 2 Ulusal Venöz Tromboembolizm Profilaksi ve Tedavi Kilavuzu, Ulusal , Cortex Iletisim Hizmetleri A.S., 2010.

.M. A. DEMIR, 3 Türk Hematoloji Dernegi Ulusal Tani ve Tedavi Kilavuzu 2010, Ulusal , Eflatun Basin Dagitim ve Yayincilik Danismanlik Yatirim ve Tic Ltd. Sti. Ankara, 2010.

H Indeksi (Scopus ): 30

» Educational Qualifications

High School » Graduated in 1980

Bachelor`s Degree » Graduated in 1987

Doctoral Degree » Graduated in 1992

Doctoral Degree Thesis;

Doctoral Degree » Graduated in 1997

Doctoral Degree Thesis;

Post-Doctoral Studies » Graduated in 2001

Post-Doctoral Studies » Graduated in 2003

Bachelor`s Degree » Graduated in 2021

Master`s Degree » Graduated in 2024

Associate`s Degree » Ongoing..

» Academic Titles

Doctor of Medicine » In 1987

Consultant » In 1992

Consultant » In 1997

Assistant Professor. $, Doctor of Medicine » In 1997

Associate Professor $, Doctor of Medicine » In 2002

Professor Doctor » In 2007

» Publications

SCI-SSCI or SCI Expanded Articles

International Articles

International Conference Proceedings

International Conferences and Symposiums

International Books and Book Chapters

National Articles

National Conference Proceedings

National Conferences and Symposiums

National Books and Book Chapters

Doctoral Dissertations Advised

Editorial Positions

Referee Positions

Projects

Other